Articles of Japanese Journal of Transfusion and Cell Therapy | Volume 66, Issue 2 / 2020

Search by Journal

HOME
> Search by Journal
> Japanese Journal of Transfusion and Cell Therapy

Japanese Journal of Transfusion and Cell Therapy

Volume 66, Issue 2 / 2020

English Article

Japanese Article

Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.

	Role of transfusion medical care and the transfusion society in our country 高松純樹 Japanese Journal of Transfusion and Cell Therapy 66(2): 187-187, 2020.

	We inherit the wisdom of ancient people in the next generation 大戸斉 Japanese Journal of Transfusion and Cell Therapy 66(2): 189-189, 2020.

	Entrust a young person carrying the future of transfusion, the cell therapy 高橋孝喜 Japanese Journal of Transfusion and Cell Therapy 66(2): 191-191, 2020.

	TM1-1. We will survey it with the current situation of the HLA half agreement transplant using cyclophosphamide after the transplant in the future 杉田純一 Japanese Journal of Transfusion and Cell Therapy 66(2): 193-193, 2020.

	TM1-2. The current situation and the future prospects of the cord-blood transplant 山本久史 Japanese Journal of Transfusion and Cell Therapy 66(2): 193-193, 2020.

	TM1-3. HLA1 locus mismatch transplant using the weight loss ATG 諫田淳也 Japanese Journal of Transfusion and Cell Therapy 66(2): 194-194, 2020.

	TM1-4. Cooperation and the future prospects in the hematopoietic cells transplant judging from HCTC 山崎奈美恵 Japanese Journal of Transfusion and Cell Therapy 66(2): 194-194, 2020.

	TM1-5. The current situation of the acquired tolerance instruction in the kidney transplantation and the future prospects 堀田記世彦 Japanese Journal of Transfusion and Cell Therapy 66(2): 195-195, 2020.

	TM2-1. - that the development - mesenchyma system stem cell of the reproduction therapy for the hepatocirrhosis using the mesenchyma system stem cell derived from an another family controls macrophage as conduct cells 寺井崇二 Japanese Journal of Transfusion and Cell Therapy 66(2): 195-195, 2020.

	TM2-2. Construction of the cell therapy using mesenchyma system cells derived from the umbilical cord and the raw materials supply system 長村登紀子 Japanese Journal of Transfusion and Cell Therapy 66(2): 196-196, 2020.

	TM2-3. The current situation of acute GVHD treatment by the TEMCELL 鬼塚真仁 Japanese Journal of Transfusion and Cell Therapy 66(2): 196-196, 2020.

	TM2-4. New stem cell preparation (products such as regenerative therapy, and the like) for patients with spinal cord injury 本望修 Japanese Journal of Transfusion and Cell Therapy 66(2): 197-197, 2020.

	TM3-1. Role of the transfusion part as the massive bleeding, thrombosis center in inside the hospital 松下正 Japanese Journal of Transfusion and Cell Therapy 66(2): 197-197, 2020.

	TM3-2. Examination about the transfusion preparation which is important to hemostasis 宮田茂樹 Japanese Journal of Transfusion and Cell Therapy 66(2): 198-198, 2020.

	TM3-3. Usefulness of suggestion - quick fibrinogen measurement of the quick monitor Ling's method of the clot hemostasis treatment 笹川智貴 Japanese Journal of Transfusion and Cell Therapy 66(2): 198-198, 2020.

	TM3-4. Cost effectiveness (cost-effectiveness) in the transfusion treatment of the hemostasis purpose 山本晃士 Japanese Journal of Transfusion and Cell Therapy 66(2): 199-199, 2020.

	TM4-1. Role of the society in the transfusion team approach in medical care 牧野茂義 Japanese Journal of Transfusion and Cell Therapy 66(2): 199-199, 2020.

	TM4-2. Efforts of the Asahikawa Medical University Hospital for the safe transfusion therapy enforcement 井戸川みどり Japanese Journal of Transfusion and Cell Therapy 66(2): 200-200, 2020.

	TM4-3. For establishment of the sustainable team approach in medical care from the situation of - medical technologist - 宮島喜文1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 200-200, 2020.

	TM4-4. It is ... from experience of ... multi-type of job cooperation education with functioning medical care team 平井みどり Japanese Journal of Transfusion and Cell Therapy 66(2): 201-201, 2020.

	SL-1. Challenge ... from team management - Imabari 岡田武史 Japanese Journal of Transfusion and Cell Therapy 66(2): 202-202, 2020.

	SL-2. The current situation of the regulation about the medical system study and future trend 佐藤典宏 Japanese Journal of Transfusion and Cell Therapy 66(2): 205-205, 2020.

	SL-3. ... that ... area demands "new blood" about the social way and blood donation in the ageing society with fewer children 木本晃 Japanese Journal of Transfusion and Cell Therapy 66(2): 207-207, 2020.

	SL-4. The task shift share that a medical technologist is demanded from 宮島喜文1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 209-209, 2020.

	SL-5. About the association between treatment with blood products and complement of various diseases 若宮伸隆 Japanese Journal of Transfusion and Cell Therapy 66(2): 211-211, 2020.

	SL-6. Efforts in carrier support Asahikawa Medical University of healthcare occupations 山本明美 Japanese Journal of Transfusion and Cell Therapy 66(2): 213-213, 2020.

	PL. Relation of me and the transfusion medical care 紀野修一 Japanese Journal of Transfusion and Cell Therapy 66(2): 215-215, 2020.

	GL. Examination of the safety of the washing platelet using BRS-A in the adult domain and the effectiveness 山中万次郎1), 小嶋俊介1), 紺野沙織1), 竹村佳代1), 赤羽由貴1), 古川聖美1), 中澤英之2), 柳沢龍1), 下平滋隆3) Japanese Journal of Transfusion and Cell Therapy 66(2): 217-217, 2020.

	ML. The TTP treatment principle that was led in VWF study 藤村吉博1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 218-219, 2020.

	EL-1. Hematopoietic stem cell transplantation and immune cell therapy update 豊嶋崇徳 Japanese Journal of Transfusion and Cell Therapy 66(2): 220-220, 2020.

	EL-2. Role of the medical technologist in the cell therapy 伊藤誠 Japanese Journal of Transfusion and Cell Therapy 66(2): 221-221, 2020.

	EL-3. Autonomy of the medical nurse to look after safely 佐々木由紀子 Japanese Journal of Transfusion and Cell Therapy 66(2): 222-222, 2020.

	EL-4. Transfusion preparation in heparin origin-related thrombocytopenia (HIT), examination of the new therapy with the plasma derivative 宮田茂樹 Japanese Journal of Transfusion and Cell Therapy 66(2): 223-223, 2020.

	EL-5. Patients based on evidence-centered transfusion therapy 安村敏 Japanese Journal of Transfusion and Cell Therapy 66(2): 224-224, 2020.

	EL-6. Blood business and hematopoietic stem cell transplantation (from the situation of the patients) 遠藤嘉浩 Japanese Journal of Transfusion and Cell Therapy 66(2): 225-225, 2020.

	EL-7. HB vaccine commuter pass inoculation and transfusion 四柳宏 Japanese Journal of Transfusion and Cell Therapy 66(2): 226-226, 2020.

	IS1-1. WHY PBM IS NO LONGER AN OPTION. IT'S A NECESSITY Aryeh Shander Japanese Journal of Transfusion and Cell Therapy 66(2): 227-228, 2020.

	IS1-2. How to implement PBM in China Hongwen Ji Japanese Journal of Transfusion and Cell Therapy 66(2): 231-231, 2020.

	IS1-3. Primum Non Nocere - First Do No Harm James Reynolds Japanese Journal of Transfusion and Cell Therapy 66(2): 233-234, 2020.

	IS1-4. Patient blood management in patients with hematologic disorders 豊嶋崇徳 Japanese Journal of Transfusion and Cell Therapy 66(2): 236-236, 2020.

	IS1-5. Practice of PBM in the field of digestive surgery 川元俊二 Japanese Journal of Transfusion and Cell Therapy 66(2): 238-238, 2020.

	IS2-1. Basic Concepts, History of Development and Future Perspectives in CAR-T Cell Therapy 今井千速 Japanese Journal of Transfusion and Cell Therapy 66(2): 240-240, 2020.

	IS2-2. Of the CAR-T cellular therapy for recurrent intractable DLBCL, actually 大西康 Japanese Journal of Transfusion and Cell Therapy 66(2): 242-242, 2020.

	IS2-3. Practical issues and solutions in the implementation of quality management system for CAR-T in hospitals 加畑馨 Japanese Journal of Transfusion and Cell Therapy 66(2): 244-244, 2020.

	IS2-4. Impact of Product Attributes of Tisagenlecleucel anti-CD19 CAR-T Cell Therapy on Clinical Outcomes in DLBCL patients. Margit Jeschke Japanese Journal of Transfusion and Cell Therapy 66(2): 246-246, 2020.

	AS-1. Challenges and Strategies for Future Blood Supply in Taiwan Kuo-Wei Ho1), Yun-Yuan Chen2), Lei Li2), Chi-Ming Hung1), Sheng-Mou Hou2) Japanese Journal of Transfusion and Cell Therapy 66(2): 247-247, 2020.

	AS-2. Hospital Information System and Transfusion Safety : Experience Sharing from a Tertiary Hospital in Taiwan Ying-Ju Chen1), Shin-Shang Chou2), Hsiu-Fang Yen2), Kuan-Jui Tseng2), Jia-En Hou2), Yu-Te Shen3), Chih-Jen Hsueh3), Chun-Yu Liu1) Japanese Journal of Transfusion and Cell Therapy 66(2): 249-249, 2020.

	S-1-1. Thing to overlook in the Japanese Red Cross Society blood center 安村敏, 道野淳子 Japanese Journal of Transfusion and Cell Therapy 66(2): 251-251, 2020.

	S-1-2. The new infection factor screening system 石丸健 Japanese Journal of Transfusion and Cell Therapy 66(2): 251-251, 2020.

	S-1-3. A community medical care design and transfusion medical care 河原和夫, 菅河真紀子 Japanese Journal of Transfusion and Cell Therapy 66(2): 252-252, 2020.

	S-1-4. Demand and raw materials plasma sampling of the IVIG 村井利文 Japanese Journal of Transfusion and Cell Therapy 66(2): 252-252, 2020.

	S-2-1. The transfusion system and cloud type emergency care cooperation support project in Asahikawa Medical Univ. 藤井聡1), 花田大輔2), 大塚浩平2), 斉藤史頼2), 山中まゆみ2) Japanese Journal of Transfusion and Cell Therapy 66(2): 253-253, 2020.

	S-2-2. Study of the effective blood products operation in the remote island area 長井一浩1), 泊徳幸2), 江川佐登子3), 古賀嘉人1), 今西大介2), 都能克博4), 近藤徹5), 松尾辰樹3), 宮崎泰司1), 田中朝志6) Japanese Journal of Transfusion and Cell Therapy 66(2): 253-253, 2020.

	S-2-3. Community medical care planning and transfusion medical care 北井暁子 Japanese Journal of Transfusion and Cell Therapy 66(2): 254-254, 2020.

	S-2-4. Attempt of the blood rotation to secure the safety of the local obstetrics and gynecology department institution, and to plan utilization of the blood donation blood 長谷川雄一1), 大越靖2), 石渡勇3), 佐藤純一4), 森島耕生4) Japanese Journal of Transfusion and Cell Therapy 66(2): 254-254, 2020.

	S-2-5. Examination of transfusion support in the area 丸山美津子 Japanese Journal of Transfusion and Cell Therapy 66(2): 255-255, 2020.

	S-2-6. A problem and the future prospects of the at-home transfusion 藤田浩 Japanese Journal of Transfusion and Cell Therapy 66(2): 255-255, 2020.

	S-3-1. Usefulness of the use of FFP actual situation and the FFP division preparation of children in our hospital 奥田誠 Japanese Journal of Transfusion and Cell Therapy 66(2): 256-256, 2020.

	S-3-2. Criteria for use of food additives of the potassium adsorption filter to a 2017 blood products use fact-finding report (the division preparation, exchange blood transfusion) and small capacity preparation 藤田浩 Japanese Journal of Transfusion and Cell Therapy 66(2): 256-256, 2020.

	S-3-3. About neonates transfusion guidelines information - cytomegalovirus-negative blood - 北澤淳一 Japanese Journal of Transfusion and Cell Therapy 66(2): 257-257, 2020.

	S-3-4. A problem and solution in the medical security in the neonates transfusion 網塚貴介 Japanese Journal of Transfusion and Cell Therapy 66(2): 257-257, 2020.

	S-3-5. Thing - that image - association society will aim in the future of the neonates transfusion 細野茂春 Japanese Journal of Transfusion and Cell Therapy 66(2): 258-258, 2020.

	S-4-1. Basic knowledge of the iron-metabolism necessary for transfusion medical care 藤原亨1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 258-258, 2020.

	S-4-2. Various examinations associated with the transfusion medical care 齋藤豪志1), 生田克哉2), 奥村利勝1) Japanese Journal of Transfusion and Cell Therapy 66(2): 259-259, 2020.

	S-4-3. Cells, the organ derangement that posttransfusion hyperferremia causes 堀口拓人, 小船雅義 Japanese Journal of Transfusion and Cell Therapy 66(2): 259-259, 2020.

	S-4-4. A treatment guideline of the posttransfusion hyperferremia and future development 鈴木隆浩 Japanese Journal of Transfusion and Cell Therapy 66(2): 260-260, 2020.

	S-5-1. A clinical transfusion nurse from fact-finding about the patients with transfusion second response observation after the role - transfusion start to achieve for prevention of aggravation - 松本真弓 Japanese Journal of Transfusion and Cell Therapy 66(2): 260-260, 2020.

	S-5-2. The posttransfusional patients observation in the transfusion 西岡純子 Japanese Journal of Transfusion and Cell Therapy 66(2): 261-261, 2020.

	S-5-3. The patients observation and efforts to provide foreign transfusion safely 守岩美紀1), 岩嵜美雪1), 川内沙織2), 小森幸子2), 坂口武司2), 木村文彦2,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 261-261, 2020.

	S-5-4. Transfusion nursing during haemodialysis 大竹美和 Japanese Journal of Transfusion and Cell Therapy 66(2): 262-262, 2020.

	S-5-5. Importance of the patients observation in the urgent transfusion, massive blood transfusion 山本由加里 Japanese Journal of Transfusion and Cell Therapy 66(2): 262-262, 2020.

	S-6-1. Consideration about "the scientific grounds" of guidelines 冨山佳昭 Japanese Journal of Transfusion and Cell Therapy 66(2): 263-263, 2020.

	S-6-2. The topic around the washing platelet: Basic examination in the washing platelet manufacture 及川伸治 Japanese Journal of Transfusion and Cell Therapy 66(2): 263-263, 2020.

	S-6-3. The topic around the washing platelet: The clinical effectiveness of the washing platelet 藤原慎一郎 Japanese Journal of Transfusion and Cell Therapy 66(2): 264-264, 2020.

	S-6-4. ITP and platelet transfusion 柏木浩和1), 冨山佳昭1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 264-264, 2020.

	S-6-5. The condition of a patient and platelet transfusion of various kinds of thrombocytopenia: TTP and platelet transfusion 久保政之, 松本雅則 Japanese Journal of Transfusion and Cell Therapy 66(2): 265-265, 2020.

	S-6-6. The condition of a patient and platelet transfusion of various kinds of thrombocytopenia: Aplastic anemia and platelet transfusion 山崎宏人 Japanese Journal of Transfusion and Cell Therapy 66(2): 265-265, 2020.

	S-7- Chairman. We scientize new blood type KANNO 大戸斉 Japanese Journal of Transfusion and Cell Therapy 66(2): 266-266, 2020.

	S-7-1. KANNO erythrocyte antigen, an antibody and clinical significance 内川誠1), 伊藤正一2) Japanese Journal of Transfusion and Cell Therapy 66(2): 266-266, 2020.

	S-7-2. The gene which determines KANNO antigen 徳永勝士, 大前陽輔 Japanese Journal of Transfusion and Cell Therapy 66(2): 267-267, 2020.

	S-7-3. Antigen expression experiment and prion protein 伊藤正一1), 和田郁夫2), 小笠原健一3) Japanese Journal of Transfusion and Cell Therapy 66(2): 267-267, 2020.

	S-8-1. The general remarks (cancer practice and anemia) 小船雅義, 堀口拓人 Japanese Journal of Transfusion and Cell Therapy 66(2): 268-268, 2020.

	S-8-2. The situation of the transfusion therapy in the outpatient in our hospital 福吉葉子1), 米村雄士1), 吉田朝子1), 石原綾子1), 崎田紫織1), 内場光浩1), 松岡雅雄1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 268-268, 2020.

	S-8-3. Oncology Emergency and transfusion 藤井聡 Japanese Journal of Transfusion and Cell Therapy 66(2): 269-269, 2020.

	S-8-4. About digestive organ cancer surgical treatment ... based on PBM (patients-centered transfusion medical care) particularly Jehovah's Witnesses and elderly people 川元俊二1), 寺島孝弘2), 山本孝太2), 新みゆき2), 佐々木赳至2), 黒木則光2) Japanese Journal of Transfusion and Cell Therapy 66(2): 269-269, 2020.

	S-8-5. Mild medical care and transfusion (the transfusion medical care support system in the at-home and small medical institution) 末岡榮三朗 Japanese Journal of Transfusion and Cell Therapy 66(2): 270-270, 2020.

	S-9-1. Transfusion education at the small and medium size hospital where a physician is not specialized in the transfusion 岩尾憲明 Japanese Journal of Transfusion and Cell Therapy 66(2): 270-270, 2020.

S-9-2. Transfusion workshop for the medical technologists of the small and medium size scale institution by Fukuoka combination transfusion therapy Committee
小田秀隆1,9), 大崎浩一2,9), 天本貴広2,9), 蒲原香苗3,9), 藤好麻衣2,9), 篠田大輔4,9), 西津將巨5,9), 森山真希6,9), 前田結香7,9), 江頭弘一2,9), 松崎浩史1,9), 熊川みどり8,9)
Japanese Journal of Transfusion and Cell Therapy 66(2): 271-271, 2020.

	S-9-3. Practice of the transfusion education for the local inclusion care in the transfusion therapy 松本真弓1,2), 松谷卓周1,3), 坊池義浩1,4), 大岡徹彦1,5), 平井みどり1,6), 杉本健1,7), 藤盛好啓1,8) Japanese Journal of Transfusion and Cell Therapy 66(2): 271-271, 2020.

	S-9-4. Video production and instructional activity about the transfusion enforcement of the nurse 木村秀実1), 池淵研二2), 山嵜恵美子3), 小林祥一4), 坂本里恵5), 小杉山めぐみ6), 島村麻実6), 太田茂7), 松田充俊7) Japanese Journal of Transfusion and Cell Therapy 66(2): 272-272, 2020.

	S-9-5. Transfusion instructional activity by the nurse seminar in Hokkaido 藤理沙 Japanese Journal of Transfusion and Cell Therapy 66(2): 272-272, 2020.

	S-10-1. Pollution and measures of the blood culture 中江舞美 Japanese Journal of Transfusion and Cell Therapy 66(2): 273-273, 2020.

	S-10-2. A cause and the condition of a patient of the bloodstream infection 藤田崇宏 Japanese Journal of Transfusion and Cell Therapy 66(2): 273-273, 2020.

	S-10-3. The current situation of transfusion bacterial infections 後藤直子 Japanese Journal of Transfusion and Cell Therapy 66(2): 274-274, 2020.

	S-10-4. Clinical practice of sepsis with the transfusion 加藤栄史 Japanese Journal of Transfusion and Cell Therapy 66(2): 274-274, 2020.

	PD-1-1. Examination for the pharmaceutical approval of the fibrinogen concentration preparation 牧野真太郎 Japanese Journal of Transfusion and Cell Therapy 66(2): 275-275, 2020.

	PD-1-2. Importance of the fibrinogen concentration preparation in the cardiovascular surgery domain 碓氷章彦 Japanese Journal of Transfusion and Cell Therapy 66(2): 275-275, 2020.

	PD-1-3. Difference between fibrinogen concentrate and cryoprecipitate 松本雅則 Japanese Journal of Transfusion and Cell Therapy 66(2): 276-276, 2020.

	PD-1-4. Examination of the trigger level of the fibrinogen preparation administration 香取信之 Japanese Journal of Transfusion and Cell Therapy 66(2): 276-276, 2020.

	PD-2-1. It will be ... to transfusion life - this of me from now on 田島正輝 Japanese Journal of Transfusion and Cell Therapy 66(2): 277-277, 2020.

	PD-2-2. Working together - with our "way of working reform" - multi-type of job 吉田昌弘 Japanese Journal of Transfusion and Cell Therapy 66(2): 277-277, 2020.

	PD-2-3. Settings power 篠田大輔, 松崎沙耶, 山田麻未, 小山和恵 Japanese Journal of Transfusion and Cell Therapy 66(2): 278-278, 2020.

	PD-2-4. It has just begun until now as the transfusion laboratory technician 櫻澤貴代 Japanese Journal of Transfusion and Cell Therapy 66(2): 278-278, 2020.

	ST-1-1. Step of hospital information system seven years 大谷慎一 Japanese Journal of Transfusion and Cell Therapy 66(2): 279-279, 2020.

	ST-1-2. Rebuilding of the blood products ordering system 井上正弘1), 大谷慎一2), 濱田雅俊1), 瀧川正弘1), 高橋孝喜1) Japanese Journal of Transfusion and Cell Therapy 66(2): 279-279, 2020.

	ST-1-3. For practical use of the traceability 浜口功 Japanese Journal of Transfusion and Cell Therapy 66(2): 280-280, 2020.

	ST-1-4. Efforts for the improvement of the patients security about medical information system of JAHIS 坂西裕1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 280-280, 2020.

	ST-2-1. About use of blood products fact-finding 菅野仁1), 岡本好雄1), 北澤淳一2), 安村敏3), 山本晃士4), 横濱章彦5), 米村雄士6), 牧野茂義7) Japanese Journal of Transfusion and Cell Therapy 66(2): 281-281, 2020.

	ST-2-2. Activity report of Ishikawa combination transfusion therapy Committee 山崎宏人 Japanese Journal of Transfusion and Cell Therapy 66(2): 281-281, 2020.

	ST-2-3. Activity report of Okinawa combination transfusion therapy Committee 大城正巳 Japanese Journal of Transfusion and Cell Therapy 66(2): 282-282, 2020.

	ST-2-4. Activity of Chiba combination transfusion therapy Committee 井関徹1), 前橋美智子2), 脇田久2) Japanese Journal of Transfusion and Cell Therapy 66(2): 282-282, 2020.

	ST-2-5. Activity report of Akita combination transfusion therapy Committee 面川進 Japanese Journal of Transfusion and Cell Therapy 66(2): 283-283, 2020.

	ST-3-1. About the revision of examination for erythrocytic form (examination for erythrocytic series) guidelines 三浦邦彦1,2), 池本純子2), 石丸健2), 内川誠2), 奥田誠2), 梶原道子2), 北澤淳一2), 国分寺晃2), 小山典久2), 竹下明裕2), 安田広康2) Japanese Journal of Transfusion and Cell Therapy 66(2): 283-283, 2020.

	ST-3-2. About the correspondence to the unexpected response of the examination for ABO blood group 浅野尚美 Japanese Journal of Transfusion and Cell Therapy 66(2): 284-284, 2020.

	ST-3-3. ABO blood group and preparation choice after the ABO incompatibility hematopoietic stem cell transplantation 櫻澤貴代 Japanese Journal of Transfusion and Cell Therapy 66(2): 284-284, 2020.

	ST-3-4. ABO blood group and preparation choice of the urgent transfusion 村井良精 Japanese Journal of Transfusion and Cell Therapy 66(2): 285-285, 2020.

	ES-1-1. Authorized transfusion laboratory technician system summary 加藤栄史 Japanese Journal of Transfusion and Cell Therapy 66(2): 286-286, 2020.

	ES-1-2. About an authorized transfusion laboratory technician system combination workshop 奥嶋博美 Japanese Journal of Transfusion and Cell Therapy 66(2): 286-286, 2020.

	ES-1-3. The technique that "is faithful to basics" that is demanded from an authorized transfusion laboratory technician 松浦秀哲 Japanese Journal of Transfusion and Cell Therapy 66(2): 287-287, 2020.

	ES-1-4. Knowledge - to want you should put knowledge - intellect necessary for an authorized transfusion laboratory technician or to know it 池本純子 Japanese Journal of Transfusion and Cell Therapy 66(2): 287-287, 2020.

	ES-1-5. As an authorized transfusion laboratory technician from trace and this to - this - 谷越悠耶 Japanese Journal of Transfusion and Cell Therapy 66(2): 288-288, 2020.

	ES-2-1. Current situation and problem - basic tone report ... of the cooperation system of a physician, a nurse, the medical technologist 小松久美子1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 288-288, 2020.

	ES-2-2. Evolution and deepening of the preserved blood-style autotransfusion to be carried out by team approach in medical care 平松靖史 Japanese Journal of Transfusion and Cell Therapy 66(2): 289-289, 2020.

	ES-2-3. About the cooperation system of a physician, a nurse, the medical technologist in the autotransfusion 足立栄子 Japanese Journal of Transfusion and Cell Therapy 66(2): 289-289, 2020.

	ES-2-4. Can do what for current situation and problem - medical technologist of the cooperation system in a physician, a nurse, the medical technologist; or ... 丸橋隆行 Japanese Journal of Transfusion and Cell Therapy 66(2): 290-290, 2020.

	ES-2-5. It is ... mainly on the change (plan) of the application qualification at/update at the authorized acquisition of problem ... physician of society authorization, the autotransfusion physician nurse system 脇本信博 Japanese Journal of Transfusion and Cell Therapy 66(2): 290-290, 2020.

	ES-3-1. From the beginning of society authorization, the clinical transfusion nurse system to the present 大戸斉 Japanese Journal of Transfusion and Cell Therapy 66(2): 291-291, 2020.

	ES-3-2. Activity - new face training ... of society authorization, the clinical transfusion nurse 齋藤紗英子 Japanese Journal of Transfusion and Cell Therapy 66(2): 291-291, 2020.

	ES-3-3. Being wished society authorization from now on by a clinical transfusion nurse 牧野茂義 Japanese Journal of Transfusion and Cell Therapy 66(2): 292-292, 2020.

	ES-3-4. Skill up and qualification system of the life 100 years times nurse 荒木暁子 Japanese Journal of Transfusion and Cell Therapy 66(2): 292-292, 2020.

	ES-4-1. Basic knowledge of Plerixafor 上田恭典 Japanese Journal of Transfusion and Cell Therapy 66(2): 293-293, 2020.

	ES-4-2. From the situation of use experience and the problem (1) physician of Plerixafor 三村尚也 Japanese Journal of Transfusion and Cell Therapy 66(2): 293-293, 2020.

	ES-4-3. From the situation of use experience and the problem (2) nurse of Plerixafor 猪越ひろむ Japanese Journal of Transfusion and Cell Therapy 66(2): 294-294, 2020.

	ES-4-4. From the situation of use experience and the problem (3) laboratory technician of Plerixafor 杉本達哉 Japanese Journal of Transfusion and Cell Therapy 66(2): 294-294, 2020.

	ES-4-5. As experience - coordinator of introduction preparations and the real (1) Tohoku University Hospital - 岩木啓太 Japanese Journal of Transfusion and Cell Therapy 66(2): 295-295, 2020.

	ES-4-6. As experience - physician of introduction preparations and the real (1) Tohoku University Hospital - 藤原実名美 Japanese Journal of Transfusion and Cell Therapy 66(2): 295-295, 2020.

	ES-4-7. Introduction preparations and experience of the hospital attached to the real (2) Tokai University faculty of medicine of the product such as regenerative therapy, and the like such as CAR-T, and the like 豊崎誠子 Japanese Journal of Transfusion and Cell Therapy 66(2): 296-296, 2020.

	ES-5-1. About the authorized situation and program contents in the new I&A system 田中朝志 Japanese Journal of Transfusion and Cell Therapy 66(2): 296-296, 2020.

	ES-5-2. I&A Ver. Reach the fifth year after 5 present situation - starts; and - 飛田規 Japanese Journal of Transfusion and Cell Therapy 66(2): 297-297, 2020.

	O-1. The detection of the antiVel antibody by the ICFA method 宮崎孔1), 佐藤進一郎1), 生田克哉2), 山本哲2), 池田久實2), 紀野修一1) Japanese Journal of Transfusion and Cell Therapy 66(2): 301-301, 2020.

	O-2. Evaluation (the second report) of the clinical significance of the IgA type antibody 北崎英晃1), 宮崎孔1), 飛田隆太郎2), 三浦佳乃1), 佐藤進一郎1), 生田克哉3), 山本哲3), 池田久實3), 紀野修一1) Japanese Journal of Transfusion and Cell Therapy 66(2): 301-301, 2020.

	O-3. The current situation of the version irregularity antibody card common throughout the prefecture in Niigata 鈴木克弥1,8), 見邉典子2,8), 木島貴志3,8), 高橋一哲4,8), 古俣妙5,8), 佐藤美里6), 上村正巳6), 牛木隆志6,8), 関義信7,8) Japanese Journal of Transfusion and Cell Therapy 66(2): 302-302, 2020.

	O-4. Analysis of the irregularity antibody detected in volunteer blood donor 玉野奈穂, 大河内直子, 増野敦子, 常山初江, 小野寺孝行, 内川誠, 津野寛和, 中島一格 Japanese Journal of Transfusion and Cell Therapy 66(2): 302-302, 2020.

O-5. It is ... about antibody prevalence and an antibody production rate except multicenter study on anti-erythrocyte antibody - maternal antibody of the minor
玉井佳子1,2), 大戸斉1,3), 藤井伸治1,4), 小郷博昭1,4), 矢澤百合香1,5), 谷内田尚美1,5), 山本晃士1,6), 阿南昌弘1,6), 三谷絹子1,7), 篠原茂1,7), 菅野仁1,8), 槍澤大樹1,8), 岡本好雄1,8), 長嶋宏晃1,9), 久米田麻衣1,2), 田中一人1,2), 山田舞衣子1,3), 北澤淳一1,10)
Japanese Journal of Transfusion and Cell Therapy 66(2): 303-303, 2020.

O-6. Examination - about expression and the contents of the transfusion second response according to multicenter study on red blood cell preparation transfusion - antibody for the irregular antibody-positive case
山田千亜希1), 竹下明裕1), 石丸健2), 川畑絹代3), 野間口由利子4), 原口安江5), 阿部操6), 祖父江晃基7), 竹ノ内博之8), 高舘潤子9), 上村正巳10), 高橋孝喜2), 大戸斉3)
Japanese Journal of Transfusion and Cell Therapy 66(2): 303-303, 2020.

	O-7. Evaluation of the clinical significance of the HPA-5 antibody by the platelet englobement study 高橋大輔, 清水まり恵, 内田みゆき, 鎌田裕美, 高田愼之介, 中島文明, 宮田茂樹, 佐竹正博 Japanese Journal of Transfusion and Cell Therapy 66(2): 304-304, 2020.

	O-8. Example that antiJra possession became clear to mother than the direct antiglobulin test results of children 岡本彩1), 川上麻里絵1), 山口大介1), 香林優佳1), 長谷美里1), 北森久美子1), 正木康史1,2), 水田秀一1,2), 川端浩1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 304-304, 2020.

	O-9. AntiJra and example that transfused the antiJka possession patients with different RBC of the ABO blood group 山田遥子, 成田唯, 若山亜由美, 佐々木淳, 森田曜江 Japanese Journal of Transfusion and Cell Therapy 66(2): 305-305, 2020.

	O-10. Efforts of test tube Home laying upon in the internal quality control 岩上薫1), 瀧澤かすみ1), 黒沢英里1), 小峰弘美1), 原田佐保1), 山崎悦子2), 柴徳生1,3), 上條亜紀1) Japanese Journal of Transfusion and Cell Therapy 66(2): 305-305, 2020.

	O-11. The current situation and problems of the examination of Japanese Association of Medical Technologists control survey transfusion section report transfusion 三浦邦彦1), 福吉葉子2), 西岡純子3), 国分寺晃4), 奥田誠5) Japanese Journal of Transfusion and Cell Therapy 66(2): 306-306, 2020.

	O-12. Than 2 2019 Japanese Association of Medical Technologists control survey - transfusion examination fact-finding - 福吉葉子1), 西岡純子2), 国分寺晃3), 三浦邦彦4), 奥田誠5) Japanese Journal of Transfusion and Cell Therapy 66(2): 306-306, 2020.

	O-13. About a meeting, the workshop system which supported transfusion medical care, blood business of Akita 阿部真, 面川進 Japanese Journal of Transfusion and Cell Therapy 66(2): 307-307, 2020.

O-14. Activity results ... for inspection training - eight years of the institution of the prefecture model by Gifu combination transfusion therapy Committee
福岡玲1,10), 脇坂志保2,10), 浅野栄太3,10), 角田明美2,10), 樋口布抄子4,10), 鳥居知美5,10), 伊藤裕子5,10), 森本剛史2,10), 二宮空暢3,10), 北川順一3,10), 後藤英子6,10), 植田米男7,10), 林勝知7), 高橋健8,10), 小杉浩史5,9,10)
Japanese Journal of Transfusion and Cell Therapy 66(2): 307-307, 2020.

O-15. Attitude survey before Choosing Wisely Akita Transfusion Medicine Campaign and the start
藤島直仁1,2), 吉田斉3), 國井華子3), 寺田亨3), 阿部真2,3), 佐藤弘美2,4), 上村克子2,5), 小塚源儀2,6), 林崎久美子2,7), 加賀谷聡2,8), 道下吉広2,9), 小笠原仁2,6), 西成民夫2,10), 星野良平2,4), 面川進2,3)
Japanese Journal of Transfusion and Cell Therapy 66(2): 308-308, 2020.

O-16. Efforts of Fukuoka combination transfusion therapy Committee for the purpose of the transfusion medical care support of small and medium size medical facilities, the multi-type of job taskforce
大崎浩一1), 小田秀隆2,5), 江頭弘一1,5), 天本貴広1,5), 藤好麻衣1,5), 西津将臣5), 篠田大輔5), 甲斐純美5), 梅木智美5), 阿部智美5), 柳田久枝5), 磯崎章子5), 星本美樹5), 平安山知子3,5), 熊川みどり4,5)
Japanese Journal of Transfusion and Cell Therapy 66(2): 308-308, 2020.

O-17. Process until Gunma transfusion-related transfusion workshop holding by the authorized nurse society
中西文江1), 高橋美幸1), 大河原麻由美1), 鈴木浩子2), 新井タカネ3), 高柳愛美4), 栗原愛子5), 渡辺悦子1), 野口真理子1), 菊池美江7), 福田沙也加7), 横手恵子7), 伊藤浩志6), 坂倉慶太6), 丸橋隆行7), 丸山健一6), 小倉秀充1), 横濱章彦7)
Japanese Journal of Transfusion and Cell Therapy 66(2): 309-309, 2020.

	O-18. Practice on the occasion of the nurse sectional meeting setting in Niigata combination transfusion therapy Committee and the subsequent prospects and problem 関義信1,4), 瀬下敏2,4), 古俣妙2,4), 高頭成子3,4), 布施一郎2,4) Japanese Journal of Transfusion and Cell Therapy 66(2): 309-309, 2020.

	O-19. The use situation and examination of the urgent different group blood transfusion in our hospital emergency visit 渡辺悦子1), 藤塚健次2), 野口真理子1), 阿部奈規3), 小倉秀充4) Japanese Journal of Transfusion and Cell Therapy 66(2): 310-310, 2020.

	O-20. About the current situation of the urgent transfusion in our hospital 南里隆憲1), 野田祐絵1), 尾関一輝2), 北村勇1), 脇田充史1) Japanese Journal of Transfusion and Cell Therapy 66(2): 310-310, 2020.

	O-21. About the current situation of the urgent transfusion in our hospital 田部裕二1), 小本美奈1), 有馬和奈1), 岩切文子1), 山辺晴美1), 山本満里奈1), 宮崎浩二2), 大谷慎一2) Japanese Journal of Transfusion and Cell Therapy 66(2): 311-311, 2020.

O-22. It is ... for possibility - massive blood transfusion protocol introduction of the disposal preparation reduction by the expiration date for use change after the fresh frozen plasma fusion
野崎晶太1), 野間慎尋1), 栗田絵美1), 廣瀬祥子1), 山岡愛子1), 小松真由美1), 矢内綾佳1), 柏原真由1), 石井綾華1), 石田誠子2), 井上暢子2), 山崎尚也2), 藤井輝久2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 311-311, 2020.

	O-23. Analysis of the O-type RBC transfusion case for the massive blood transfusion protocol (MTP) development in our hospital first aid department 成田香魚子, 関修, 伊藤智啓, 細川真梨, 郷野辰幸, 岩木啓太, 石岡夏子, 阿部真知子, 佐藤裕子, 藤原実名美, 張替秀郎 Japanese Journal of Transfusion and Cell Therapy 66(2): 312-312, 2020.

	O-24. Inflection of MTP to an obstetric bleeding case 楠本壽子, 山本容子, 張允禧, 西村綾乃, 吉田昌弘, 江藤正明 Japanese Journal of Transfusion and Cell Therapy 66(2): 312-312, 2020.

	O-25. Basic performance and introduction effect of blood clot analyzer FibCare 伊藤英史 Japanese Journal of Transfusion and Cell Therapy 66(2): 313-313, 2020.

O-26. Effect on PT activity with the in-hospital preparation cryoprecipitate administration and fibrinogen levels
小山内崇将1,2,3,4,5), 金子なつき1), 田中一人1), 大和美都1), 阿島光1), 内田亮1), 照井健一郎3), 小笠原脩3), 中田良子3), 櫛引美穂子3), 田中幹二2), 横山良仁2), 花田裕之4), 廣田和美5), 萱場広之3), 玉井佳子1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 313-313, 2020.

	O-27. The operational results of the cryoprecipitate in our hospital 浅野栄太, 谷口寿章, 日比由佳, 石田秀和, 大橋葉津希, 佐藤弦士朗, 二宮空暢, 北川順一, 伊藤弘康 Japanese Journal of Transfusion and Cell Therapy 66(2): 314-314, 2020.

	O-28. The current situation of the cryoprecipitate offer in our hospital and future problem 前田結香1), 藤島充弘1), 高橋明子1), 得能寛子1), 鷹野壽代2) Japanese Journal of Transfusion and Cell Therapy 66(2): 314-314, 2020.

	O-29. Tranexamic acid for the severe head trauma, cryoprecipitate combined effect 杉山和宏1), 西村滋子2), 寺谷美雪3), 浅香祐幸3), 中原美千代3), 間由紀3), 大谷彩恵3), 藤田浩2) Japanese Journal of Transfusion and Cell Therapy 66(2): 315-315, 2020.

	O-30. The effectiveness of the fibrinogen preparation for the severe head trauma 藤原岳1,2), 村上守2), 丸山大輔2), 村上陳訓2), 飯塚亮二3), 橋本直哉1) Japanese Journal of Transfusion and Cell Therapy 66(2): 315-315, 2020.

	O-31. Preparations and correspondence of the transfusion part for the system update 飯田文緒1), 中村和代1), 木村愛子1), 上村美帆1), 石渡愛実1), 深川良子1), 小倉亜砂巳2), 菅谷文乃2), 竹森美紀2), 沼田歩3), 藤澤信3), 野崎昭人1) Japanese Journal of Transfusion and Cell Therapy 66(2): 316-316, 2020.

	O-32. Examination about usefulness and the safety of the computer cross match of our hospital 蓮輪亮介1), 井手真結子1), 屋田龍哉1), 藤野恵三1,2), 田守昭博1,3), 河田則文1,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 316-316, 2020.

O-33. For problems and 100% of measures - specimen collation rates shown clearly by specimen non-collation fact-finding results -
榛葉隆人1), 石塚恵子1), 藤原晴美1), 山田千亜希1), 芝田大樹1), 古牧宏啓1), 根本直紀1), 猪野楓1), 小沢茜香里1), 渡邊弘子1), 國清遼平2), 川島知晃2), 鈴木綾子2), 小幡由佳子1), 竹下明裕1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 317-317, 2020.

	O-34. We think from correspondence, the incident to a transfusion blunder, a here rehat example 舞木弘幸, 宮元珠華, 外室喜英, 濱田平一郎, 古川良尚 Japanese Journal of Transfusion and Cell Therapy 66(2): 317-317, 2020.

	O-35. Analysis of the incident example about the transfusion that a nurse was associated with 緑川由貴子, 飯島佳子, 森川嗣夫 Japanese Journal of Transfusion and Cell Therapy 66(2): 318-318, 2020.

	O-36. Analysis of the transfusion-associated incident in the hospital attached to the Jikei University School of Medicine for the past 11 years 佐藤智彦, 石井謙一郎, 山下香奈子, 石橋美由紀, 堀淑恵, 岡田亜由美, 古川悠太, 影山有美子, 早川修司, 堀口新悟, 田崎哲典 Japanese Journal of Transfusion and Cell Therapy 66(2): 318-318, 2020.

	O-37. About usefulness of the use of electronic cooling-type blood transport system in the operating room 道野淳子, 安村敏, 大槻晋也, 富山隆介, 中出祥代, 佐竹伊津子, 山本由加里, 仁井見英樹 Japanese Journal of Transfusion and Cell Therapy 66(2): 319-319, 2020.

	O-38. Two times of blood type confirmation and ABO same model transfusion enforcement processes at artificial disaster: A problem and the prospects 朝倉信之介1), 三品瑠璃子1), 橋口友恵2), 中西由佳2), 奥田慎也3), 竹林ちあき3) Japanese Journal of Transfusion and Cell Therapy 66(2): 319-319, 2020.

	O-39. Efforts to standardization of the transfusion speed 岩嵜美雪1), 守岩美紀1), 佐藤かおり2), 川内沙織2), 小森幸子2), 坂口武司2), 佐藤謙4), 木村文彦2,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 320-320, 2020.

	O-40. Consideration about a merit and the demerit of the used bag collection 福永祥子, 棚澤敬志, 河原志帆, 小林瑞紀, 須藤保加, 前田麻衣, 松本慎二, 浅見育子, 小林清子, 石田明 Japanese Journal of Transfusion and Cell Therapy 66(2): 320-320, 2020.

	O-41. Efforts led by the transfusion section for the introduction of a more effective irregularity antibody card 平松潔子, 志磨美緒, 鴨川康代, 南有美子, 渡邊由香理, 泉原由美子, 北畑建太, 河野武弘 Japanese Journal of Transfusion and Cell Therapy 66(2): 321-321, 2020.

	O-42. It is ... through efforts - antigen-positive blood transfusion example in our hospital for the transfusion-associated information card issued by other institutions 佐久間香枝, 渡邉玲, 大矢未来, 岡崎江里子, 森山昌彦, 石橋小百合, 西村加世, 中川美子, 原口京子, 奥山美樹 Japanese Journal of Transfusion and Cell Therapy 66(2): 321-321, 2020.

O-43. Transfusion enforcement situation analysis ... after construction second report - remedy enforcement of the safe transfusion system accompanied with the order ring system introduction in our hospital
高橋明子1), 前田結香1), 得能寛子1), 松川幸久1), 藤島充弘1), 梅木智美3), 井手洋昭4), 鷹野壽代2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 322-322, 2020.

	O-44. Analysis of the inspection contents by the transfusion inspection subcommittee in the hospital attached to the Jikei University School of Medicine 山下香奈子, 佐藤智彦, 石井謙一郎, 堀淑恵, 石橋美由紀, 岡田亜由美, 影山有美子, 早川修司, 堀口新悟, 田崎哲典 Japanese Journal of Transfusion and Cell Therapy 66(2): 322-322, 2020.

O-45. Enforcement of the inspection by the Yamanashi version I&A check list of activity report - serious incident occurrence of Yamanashi I&A Committee institution
高野勝弘1), 原順一2), 新田由起子3), 白倉久美子4), 中野賢一5), 高野吉彦6), 古屋直樹7), 宮咲えり子8), 後藤光善8), 東保一葉9), 塚原達幸9)
Japanese Journal of Transfusion and Cell Therapy 66(2): 323-323, 2020.

	O-46. Perform auditee of I&A, Hospital Evaluation of function, ISO15189; and from experience of - our hospital - 川井孝太1), 飛田規2), 山本麻貴1), 佐藤政季1) Japanese Journal of Transfusion and Cell Therapy 66(2): 323-323, 2020.

	O-47. Perform auditee of management - ISO15189 of the transfusion section; and - 菅野直子, 岸野光司, 大槻郁子, 秋山小雪, 今野雄斗, 長尾里桃, 武井生成, 秋山友子, 進藤聖子, 尾島佐恵子, 小林美佳, 室井一男 Japanese Journal of Transfusion and Cell Therapy 66(2): 324-324, 2020.

	O-48. Efforts and result of transfusion therapy Committee in the Saiseikai Kumamoto Hospital, experience of the JCI certification update 上杉英之1), 吉田賢太2), 北川順湖2), 黒木多美子3), 増田博紀3), 石工ひとみ3), 上野愛歩3) Japanese Journal of Transfusion and Cell Therapy 66(2): 324-324, 2020.

	O-49. Efforts in our hospital for the appropriate use of blood products 高橋聡1), 田中信悟1), 村井良精2), 盛合美加子2), 片山雄貴2), 北山育実2), 遠藤輝夫3) Japanese Journal of Transfusion and Cell Therapy 66(2): 325-325, 2020.

	O-50. Examination of the reuse of the return red blood cell preparation in inside the hospital 瀬崎晴美, 奥田誠, 栗林智子, 山田由香里, 日高陽子, 遊佐貴司, 舘野友紀, 祖父江晃基, 田中美里, 藤原ゆり, 石橋瑞樹, 佐瀬千佳, 塩野則次 Japanese Journal of Transfusion and Cell Therapy 66(2): 325-325, 2020.

	O-51. An aim and problem for the current situation of the blood products disposal reduction and the further reduction 石川貴徳, 齊藤理央, 菅原未稀, 工藤沙也果, 杉田好, 小沼善明, 鳥山満, 中島あつ子, 樋口敬和 Japanese Journal of Transfusion and Cell Therapy 66(2): 326-326, 2020.

	O-52. Demand for globulin preparation and study on proper use 菅河真紀子1), 河原和夫1), 津野寛和2), 木村洋一3), 野島清子4), 平安山知子5), 小暮孝道1), 大山功倫1), 佐川公矯6) Japanese Journal of Transfusion and Cell Therapy 66(2): 326-326, 2020.

	O-53. Why does consumption suddenly increased use fact-finding - of the intravenous immunoglobulin preparations in Nara? 久保政之1), 中村文彦2,3), 松本雅則1,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 327-327, 2020.

O-54. About the use actual situation of the human normal immunoglobulin and the current situation of the plasma exchange than - Akita combination transfusion therapy Committee investigation -
吉田斉1), 國井華子1), 寺田亨1), 阿部真1,2), 佐藤弘美2), 上村克子2), 小塚源儀2), 林崎久美子2), 加賀谷聡2), 道下吉広2), 小笠原仁2), 西成民夫2), 星野良平2), 藤島直仁2), 面川進2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 327-327, 2020.

	O-55. Efforts for the in-hospital division preparation transfusion manual preparation in the Kyushu University Hospital 蒲原香苗1), 山口恭子1), 前田茜2), 榎本麻里1), 堀田多恵子1), 平安山知子2), 前田高広2), 康東天1) Japanese Journal of Transfusion and Cell Therapy 66(2): 328-328, 2020.

	O-56. Efforts to use of safe division preparation in our hospital 佐野友美1), 井上優花子1), 小田原聖1), 外川洋子1), 後藤健治1), 高舘潤子1), 鈴木啓二朗2), 諏訪部章2) Japanese Journal of Transfusion and Cell Therapy 66(2): 328-328, 2020.

	O-57. The present situation of the role of the pharmacist in the Ogaki Municipal Hospital transfusion team approach in medical care system and future problem 竹中翔也1), 宇佐美英績1), 神田友江1), 岡田和智1,4), 吉村知哲1), 小杉浩史2,3,4) Japanese Journal of Transfusion and Cell Therapy 66(2): 329-329, 2020.

	O-58. Offer - of the transfusion medical care education to demand of Saint servant Hamamatsu Hospital transfusion team activity report - settings 中島裕美1), 秋山安里1), 大庭恵子1), 直田健太郎1), 篠崎沙織2), 島津泉2), 中村智美2), 平山亜紀2), 犬塚知依美2), 米川修3), 鈴木一史4) Japanese Journal of Transfusion and Cell Therapy 66(2): 329-329, 2020.

	O-59. To new face nurse transfusion education of our hospital wrestle 古井郁恵1), 岡本真由子1), 山本直美1), 門田恭子2), 西内聖子2), 黒川早由林2), 馬宮姫京3), 近澤成和4), 夕部富三4) Japanese Journal of Transfusion and Cell Therapy 66(2): 330-330, 2020.

	O-60. Report of the transfusion examination in the long-term new face education of our hospital to become strong in an examination for duty on a day 川崎いち恵, 五十嵐恵子, 岩田幸弘, 篠崎廣, 高野翔平, 金沢美奈, 寺門美帆, 相澤なつみ, 四方聡一郎, 関口芳恵, 池田聡 Japanese Journal of Transfusion and Cell Therapy 66(2): 330-330, 2020.

O-61. About effect on blood transfusion reaction that is hemolytic in the ABO incompatibility platelet transfusion
松橋美佳1), 礪波薫1), 岡崎晃士1), 田原綾乃1), 瀬戸勝也1), 小野あい子1), 山際裕子1), 安藤萌1), 宮城徹1), 岡島さやか1), 常山初江1), 内川誠1), 小野寺孝行1), 後藤直子2), 津野寛和1), 中島一格1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 331-331, 2020.

	O-62. About the use situation and the platelet count situation of irradiation platelet concentrate HLA-LR "Japan Red Cross" in the Kurume University Hospital 江頭弘一1), 天本貴広1), 藤好麻衣1), 池田美咲1), 吉永英子3), 柳場澄子1), 大崎浩一1,2), 長藤宏司2), 中島収1) Japanese Journal of Transfusion and Cell Therapy 66(2): 331-331, 2020.

	O-63. About an evaluation after the use of irradiation platelet concentrate HLA-LR "Japan Red Cross" in the Kurume University Hospital 江頭弘一1), 天本貴広1), 藤好麻衣1), 池田美咲1), 吉永英子3), 柳場澄子1), 大崎浩一1,2), 長藤宏司2), 中島収1) Japanese Journal of Transfusion and Cell Therapy 66(2): 332-332, 2020.

	O-64. Fact-finding of platelet transfusion unresponsiveness and the HLA matched platelet transfusion in the cancer base Hospital 山口津加彩1), 川村眞知子1,2), 湯浅博美1), 伊丹直人3), 小島典江3), 藤井絢子3), 高田梨恵3), 小林泰文1) Japanese Journal of Transfusion and Cell Therapy 66(2): 332-332, 2020.

	O-65. Blood clotting kinetic analysis when we chilled and preserved platelet preparation of the different plasma level 小池敏靖, 福田香苗, 平山順一, 柴雅之, 宮田茂樹, 五十嵐滋, 佐竹正博 Japanese Journal of Transfusion and Cell Therapy 66(2): 333-333, 2020.

	O-66. A preparation and securing of the substituted platelet preparation by the hollow thread membrane cross flow law of plasma for raw materials 林智也1), 林昭浩2), 岸川竜也2), 正木美香子1), 平山文也1), 田中光信1,3), 谷慶彦3), 藤村吉博1), 瀧原義宏1) Japanese Journal of Transfusion and Cell Therapy 66(2): 333-333, 2020.

	O-67. For autotransfusion adequacy: Making of pre-operative autologous blood donation, the transfusion pass 山崎雅英, 左近みゆき, 坂下一美, 大湯静, 櫻栄一郎, 竹中和美, 山口拓也, 谷内正人 Japanese Journal of Transfusion and Cell Therapy 66(2): 334-334, 2020.

O-68. Efforts ... to the unionization of duties before self blood drawing blood in role - our hospital of society authorization, the autotransfusion nurse
牧野桃子1,2,3), 兼石知香1,2,3), 新屋果蓮1,3), 小田原千里1,3), 中島彩乃2,3,4), 藤山裕輝2,3,4), 久保友恵4), 小田原淳1), 中野伸亮1), 宮園卓宜1), 宇都宮與1), 帆北修一3,5)
Japanese Journal of Transfusion and Cell Therapy 66(2): 334-334, 2020.

O-69. The current situation of the preserved blood-style autotransfusion in elderly people in our hospital 80 years or older
仲井富久江1), 岡井美樹1), 文屋涼子1), 永井智美1), 吉田智子1), 中桐逸博4), 廣瀬匡2), 山田聖子2), 松橋佳子2), 林清人2), 清水里紗2), 村上美香2), 宗川裕子2), 小松はるよ2), 北中明3), 辻岡貴之3), 通山薫3), 三谷茂5), 近藤英生2), 和田秀穂2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 335-335, 2020.

O-70. Inspection of the present situation after having optimized the preserved blood-style self-blood volume in placenta previa, the deep lying placenta
酒井あゆみ1), 松永茂剛2), 舘明子3), 阿南昌弘3), 中村永信1), 鮫島浩輝1), 江良澄子1), 小野義久1), 山本晃士3), 高井泰2), 関博之1), 前田平生3)
Japanese Journal of Transfusion and Cell Therapy 66(2): 335-335, 2020.

	O-71. An example in our hospital examines the need of the multi-type of job team approach in medical care in the pre-operative autologous blood donation of patients on dialysis 小見山貴代美, 辻太一, 大田恭太郎, 木村有里, 松井貴弘, 天野竜彰, 中前健二, 鈴木幸子, 鏡味良豊, 佐藤友香 Japanese Journal of Transfusion and Cell Therapy 66(2): 336-336, 2020.

	O-72. Investigation of the side effect delayed-action after the self-blood drawing blood of several institutions in Iwate 鈴木啓二朗1), 伊藤達朗2), 村井一範3), 吉田こず恵4), 諏訪部章1) Japanese Journal of Transfusion and Cell Therapy 66(2): 336-336, 2020.

	O-73. Examination about the remedy to vascular pain at the self-blood victim's blood in the transfusion round team activity 元木忍1), 前田彩1), 宮田恵理子1), 斉藤京子1), 浅香祐幸2), 寺谷美雪2), 西村滋子3), 藤田浩3) Japanese Journal of Transfusion and Cell Therapy 66(2): 337-337, 2020.

	O-74. The self-fibrin paste operation situation in our hospital 奥津美穂1,2), 渡邉万央2), 佐々木睦美2), 大堀裕子3), 小島学1), 経塚標1), 古川茂宣1), 山口明子1), 添田周1), 三村耕作2), 渡邉尚文1), 池田和彦2), 藤森敬也1) Japanese Journal of Transfusion and Cell Therapy 66(2): 337-337, 2020.

	O-75. About the peripheral blood stem cell sampling that considered aim CD34 counts and sampling time in our hospital 板垣浩行, 中塩屋千絵, 今泉満明, 小山暁史, 杉本達哉, 豊崎誠子 Japanese Journal of Transfusion and Cell Therapy 66(2): 338-338, 2020.

	O-76. Examination about the mobilization phenomenon during peripheral blood stem cell sampling 荒木美弥1,2), 三村耕作2), 大原喜裕3), 池田和彦2) Japanese Journal of Transfusion and Cell Therapy 66(2): 338-338, 2020.

	O-77. Research of cells with the immunoregulation effect included in the peripheral blood stem cell 原口京子1), 中川美子1), 渡邉玲1), 大矢未来1), 岡崎江里子1), 森山昌彦1), 石橋小百合1), 佐久間香枝1), 西村加世1), 下山達2), 大橋一輝3), 奥山美樹1) Japanese Journal of Transfusion and Cell Therapy 66(2): 339-339, 2020.

	O-78. Comparison - of transplant results - R-PBSCT and UR-PBSCT of PBSCT using a little ATG 白鳥聡一, 大東寛幸, 高橋秀一郎, 荒隆英, 横山絵美, 後藤秀樹, 杉田純一, 小野澤真弘, 中川雅夫, 加畑馨, 遠藤知之, 橋本大吾, 豊嶋崇徳 Japanese Journal of Transfusion and Cell Therapy 66(2): 339-339, 2020.

	O-79. A characteristic and precaution of the peripheral blood stem cell sampling by the combination of G-CSF and Plerixafor 高野弥奈1), 八木橋健太1), 陣場貴之1), 高橋裕衣1), 長田有生2), 成川研介2), 押川学2), 森威典1) Japanese Journal of Transfusion and Cell Therapy 66(2): 340-340, 2020.

	O-80. Examination about the CD34 weak positive domain of the use of Plerixafor patients 稲田直樹, 藤川瑞稀, 黒木沙央里, 岩切望美, 金丸恭子, 坂元あい子, 竹ノ内博之, 久冨木庸子 Japanese Journal of Transfusion and Cell Therapy 66(2): 340-340, 2020.

	O-81. About possibility of the natural killer cell therapy for the progress gastric cancer with the peritoneal dissemination 三村耕作1,2,3,4), 河野浩二2), 大戸斉1,3), 池田和彦1) Japanese Journal of Transfusion and Cell Therapy 66(2): 341-341, 2020.

	O-82. Examination of the granulocytes sampling using Spectra Optia and 6% of Hydroxyethylated starch notes 万木紀美子, 菱田理恵, 濱野京子, 澁谷江里香, 西山有紀子, 新井康之, 平位秀世, 長尾美紀 Japanese Journal of Transfusion and Cell Therapy 66(2): 341-341, 2020.

	O-83. Regenerative therapy, and the like examines a detection limit evaluation of BacT/ALERT 3D in the product production 三春祐太1,2), 高橋理3), 高橋敦子1,2), 柴田浩子3), 堀暁子1,2), 山本由紀1,2), 伊澤ゆき1,2), 東條有伸3), 長村登紀子1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 342-342, 2020.

	O-84. Examination of the cell culture ability in the serum which we made from the disposal planned plasma preparation 石山和樹1), 丹羽玲子1), 加藤栄史1), 中山享之1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 342-342, 2020.

	O-85. Examination about the optimal preparation method of Platelet lysate (PL) which assumed the PC which we could not use for transfusion raw materials 若本志乃舞1), 藤原満博1), 布施久恵1), 林宜亨1), 秋野光明2), 生田克哉2), 山本哲2), 池田久實2), 紀野修一1) Japanese Journal of Transfusion and Cell Therapy 66(2): 343-343, 2020.

	O-86. Manufacture of the mesenchyma system stem cell which raised safety by thrombomodulin gene introduction 高四強1), 加藤栄史1), 高見昭良2), 中山享之1,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 343-343, 2020.

O-87. Significance - that a transfusion nurse associates with role and practice report - apheresis nurse of the nurse in the CAR-T therapy
高木尚江1), 藤井敬子2,3), 三道康永3,4), 清家圭介3,4), 池川俊太郎3,4), 松田真幸3,4), 近藤匠3,4), 木村真衣子3), 小林宏紀3), 海内千春1), 山成洋子1), 川村夢乃1), 鈴木香織1), 閘結稀4), 池田亮4), 浅野尚美4), 小郷博昭4), 藤井伸治3,4)
Japanese Journal of Transfusion and Cell Therapy 66(2): 344-344, 2020.

O-88. Process control (and auditee does institution examination of the CAR-T cellular therapy) from raw materials sampling of the cells preparation with the apheresis to cells processing, freeze
大友直樹, 相川佳子, 伊藤千裕, 臼井友香里, 大石裕紀子, 白石暁子, 千葉美沙希, 山崎美保, 奥井愛莉, 諏訪志穂子, 水野満, 片野尚子, 梶原道子, 関矢一郎
Japanese Journal of Transfusion and Cell Therapy 66(2): 344-344, 2020.

	O-89. Efforts of our hospital transfusion part for the introduction of the Kim rear 屋田龍哉1), 蓮輪亮介1), 藤野恵三1,2), 中嶋康博3), 田守昭博1,4), 河田則文1,4), 日野雅之3) Japanese Journal of Transfusion and Cell Therapy 66(2): 345-345, 2020.

O-90. Maintenance of the transfusion section for the CAR-T cellular therapy "Kim rear" introduction
池本純子1), 小野本仁美1), 山本菜生1), 原田由紀1), 杉山寛貴1), 大塚真哉1), 大野万佑子1), 村田理恵1), 奥田典子1), 大西里歩2), 植村綾香2), 山本真由美2), 池上明香2), 高尾理紗3), 浜田彰子1), 吉原哲1), 山原研一1), 藤盛好啓1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 345-345, 2020.

O-91. QMS construction and management administration of the cell therapy section accompanied with the CAR-T introduction
岩木啓太1), 阿部真知子1), 伊藤貴子1), 沖田ひとみ2), 島貫美和子3), 伊藤智啓1), 細川真梨1), 郷野辰幸1), 石岡夏子1), 佐藤裕子1), 関修1), 成田香魚子1), 藤原実名美1), 張替秀郎1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 346-346, 2020.

	O-92. Efforts of the CAR-T cellular therapy "Kim rear" without the cell processing center introduction 山原研一1,2,3), 池本純子1), 浜田彰子2), 山本菜生1), 原田由紀1), 杉山寛貴1), 大塚真哉1), 小野本仁美1), 大野万佑子1), 村田理恵1), 奥田典子1), 吉原哲1,3), 藤盛好啓1,2,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 346-346, 2020.

	O-93. Standardization ... of activity report (the second report) - activity system of society authorization, the clinical transfusion nurse of our hospital and the foreign transfusion procedure 中永徳子, 松浦知子, 中村千恵, 下村真由, 林昌代, 国枝桃子, 臼田直美, 高橋健 Japanese Journal of Transfusion and Cell Therapy 66(2): 347-347, 2020.

	O-94. The current situation of the transfusion of our hospital and future problem 田中恵美1), 緑川由貴子1), 森川嗣夫2) Japanese Journal of Transfusion and Cell Therapy 66(2): 347-347, 2020.

	O-95. Effect of the continuous transfusion education in the A Hospital ICU 上野愛歩1), 坂本美賀子1), 黒木多美子2), 増田博紀3), 吉田賢太4), 上杉英之5) Japanese Journal of Transfusion and Cell Therapy 66(2): 348-348, 2020.

	O-96. Activity of the nurse clinical transfusion for the on-site knowledge, improvement of the initial correspondence for the severe blood transfusion reaction 一戸亜紀子, 須郷克子, 宮田優輝, 佐藤千紗斗 Japanese Journal of Transfusion and Cell Therapy 66(2): 348-348, 2020.

O-97. Preparation of the pooled platelet preparation derived from whole blood using automatic blood separation device TACSI
藤原満博1), 林宜亨1), 布施久恵1), 金敷拓見1), 若本志乃舞1), 内藤祐1), 秋野光明1), 今井正2), 山崎裕輔2), 丸田千明2), 細江薫2), 船越浩之2), 生田克哉3), 山本哲3), 池田久實3), 紀野修一1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 349-349, 2020.

	O-98. Examination of the storage temperature management of the red blood cell preparation using the seal to temperature-control 田中美里, 奥田誠, 栗林智子, 日高陽子, 山田由香里, 遊佐貴司, 舘野友紀, 祖父江晃基, 瀬崎晴美, 藤原ゆり, 石橋瑞樹, 佐瀬千佳, 塩野則次 Japanese Journal of Transfusion and Cell Therapy 66(2): 349-349, 2020.

	O-99. We look at the multicenter rear about the prospective disposal blood reduction effect by extension on expiration date of the red blood cell preparation and research it 石田明1), 奥田誠2), 加藤陽子3), 北澤淳一4), 末岡榮三朗5), 藤田浩6), 田中朝志7) Japanese Journal of Transfusion and Cell Therapy 66(2): 350-350, 2020.

	O-100. For the leukocyte collection from a leukopheresis filter for the whole blood preparation and the utilization of property analysis - white blood cell compartment - 中村仁美, 山本翠, 相良康子, 古賀智英, 島村益広, 松山博之, 入田和男 Japanese Journal of Transfusion and Cell Therapy 66(2): 350-350, 2020.

	O-101. About one case given the erythrocyte transfusion to patients with Cromer-related antibody possession 佐々木崇雄1,2,3), 岸田成美1), 岡田早苗1), 森唯2), 猿渡晃2), 米元めぐみ2), 熊本誠2), 楠見智子3), 立山英美3), 田中光信3) Japanese Journal of Transfusion and Cell Therapy 66(2): 351-351, 2020.

	O-102. About a case with suspected passenger lymphocyte syndrome 舞木弘幸1), 宮元珠華1), 外室喜英1), 濱田平一郎1), 古川良尚1), 西村博昭2), 山田保俊2) Japanese Journal of Transfusion and Cell Therapy 66(2): 351-351, 2020.

	O-104. Problems of the revision study in the autoimmune acquired FV deficiency diagnosis 内場光浩, 米村雄士 Japanese Journal of Transfusion and Cell Therapy 66(2): 352-352, 2020.

	O-105. The use situation accompanied with the operational change of the separately red blood cell preparation in our hospital 阿部操1), 大西修司1), 北睦実1), 北畑もも香1), 大澤眞輝1), 井上まどか1), 吉田由香利1), 山岡学1), 伊藤量基1,2), 野村昌作1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 353-353, 2020.

	O-106. Examination of the mother's body survival period after the antiD immunoglobulin prophylaxis to a RhD-negative pregnant woman 瀧本朋美, 李悦子, 小田直輝, 佃恵里加, 三木浩和, 安倍正博 Japanese Journal of Transfusion and Cell Therapy 66(2): 353-353, 2020.

	O-107. On the heels of mechanism of the JR blood type incompatibility: Pair analysis of 39 mother children 桂木真司1,2), 大戸斉3), 大竹丹子4), 常山初江5), 小笠原健一6), 伊佐和美6), 池田智昭2) Japanese Journal of Transfusion and Cell Therapy 66(2): 354-354, 2020.

O-108. Effective and safe inspection of the concentration substituted platelet for the childhood blood neoplastic disease
柳沢龍1,2), 山中万次郎1), 紺野沙織1,2), 竹村佳代3), 小嶋俊介1), 大倉絵梨4), 盛田大介4), 齋藤章治4), 田中美幸4), 小森一寿5), 坂下一夫5), 松澤悠6), 戸塚実2,6), 中沢洋三4)
Japanese Journal of Transfusion and Cell Therapy 66(2): 354-354, 2020.

	O-109. Blood products preparations to children with congenital heart disease to need emergency surgery just after birth 望月舞子1,2,3,4,5,6), 松島江理1), 廣瀬圭一2), 諏訪まゆみ3), 花田卓哉6), 岩城秀平6), 川口晃司5), 石崎竜司4), 堀越泰雄5) Japanese Journal of Transfusion and Cell Therapy 66(2): 355-355, 2020.

	O-110. Examination of the high titer antibody possession case that did not lead to the onset of fetuses, the fetal erythroblastosis 佐藤祐樹, 佐藤英洋, 内海真紀, 高田恵美, 福富佳代子, 山崎宏人 Japanese Journal of Transfusion and Cell Therapy 66(2): 355-355, 2020.

	O-111. Examination of the genetic background associated with the transfusion second response in patients with childhood cancer 井出裕一郎1,2,3), 柳沢龍3,4), 坂下一夫3,5), 戸塚実3), 本田孝行1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 356-356, 2020.

O-112. Analysis about the red blood cell Jra antigen decrease of the children born from the antiJra possession pregnant woman
荻山佳子1), 伊藤正一1), 李悦子2), 加藤美加3), 長沼良子3), 成田香魚子4), 梶原かおり5), 原田恵里香6), 渡邉聖司7), 柳谷朋美1), 菱沼智子1), 入野美千代1), 名村喜一郎1), 中川國利1), 大戸斉8)
Japanese Journal of Transfusion and Cell Therapy 66(2): 356-356, 2020.

	O-113. New ABCG2 mutation in the gene that we detected in Jr (a-) type volunteer blood donor of Tohoku District 伊藤正一1), 荻山佳子1), 河井妙保2), 伊佐和美3), 小笠原健一3), 入野美千代1), 菱沼智子1), 柳谷朋美1), 名村喜一郎1), 中川國利1) Japanese Journal of Transfusion and Cell Therapy 66(2): 357-357, 2020.

	O-114. Analysis of loss (esv2662319) of the XG gene in the volunteer blood donor and GATA-1-binding regional (rs311103G/C) 大河内直子1), 常山初江1), 玉野奈穂1), 増野敦子1), 佐藤七絵2), 伊佐和美2), 小笠原健一2), 小野寺孝行1), 内川誠1), 津野寛和1), 中島一格1) Japanese Journal of Transfusion and Cell Therapy 66(2): 357-357, 2020.

	O-115. Attempt of the flow cytometry in the case with suspected the B subtype and the ABO genetic analysis 槇山愛弓1), 石山和樹1), 藤田江美1), 松尾友仁1), 安藤高宣1), 高四強1), 林恵美1), 片井明子1), 丹羽玲子1), 中山享之1,2), 加藤栄史1) Japanese Journal of Transfusion and Cell Therapy 66(2): 358-358, 2020.

	O-116. Change of ABO blood group antiA antiB antibody titers in patients receiving rituximab 宮森菜々美1), 蟹江由美1), 崎本愛理1), 川上莉央1), 高崎佳苗1), 後藤文彦2), 荒井政和2), 堀内啓2), 臼杵憲祐1) Japanese Journal of Transfusion and Cell Therapy 66(2): 358-358, 2020.

	O-117. Interference and measures of the examination of transfusion to the patients using Isatuximab (antiCD38) 日高陽子, 奥田誠, 舘野友紀, 岸まい子, 佐瀬千佳, 大野眞由子, 樋口絵莉香, 塩野則次 Japanese Journal of Transfusion and Cell Therapy 66(2): 359-359, 2020.

O-118. The new cancellation method for the examination of transfusion interference of Daratumumab, precision management of the Osaka law (0.01M DTT processing) and examination using the clinical specimen
細川美香1,2), 柏木浩和2), 中山小太郎純友1), 櫻木美基子1), 中尾まゆみ1), 森川珠世1), 清川知子1), 青地寛1), 永峰啓丞1), 柴山浩彦2), 冨山佳昭1,2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 359-359, 2020.

	O-119. Fundamental researches aiming at evasion of the examination of transfusion interference of Daratumumab 登尾一平1,2), 山本隆敏1), 田邊香野1), 池田勝義1,2), 川口辰哉1,2), 上妻行則1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 360-360, 2020.

	O-120. Implementation status of blood transfusion tests for patients treated with daratumumab at our hospital 岩瀬友也1), 可児里美1), 中村真衣1), 小池史泰1), 高木和美1), 李政樹2,3), 中西良一2,4) Japanese Journal of Transfusion and Cell Therapy 66(2): 360-360, 2020.

O-121. Domestic collaborative investigation about transfusion laboratory problems about antiCD38 antibody treatment and the actions to be taken
山田千亜希1), 竹下明裕1), 名倉豊2), 李悦子3), 川畑絹代4), 万木紀美子5), 道野淳子6), 日高陽子7), 大友直樹8), 林泰弘9), 谷田部元野10), 三浦康生5), 岡崎仁2), 大戸斉4)
Japanese Journal of Transfusion and Cell Therapy 66(2): 361-361, 2020.

	O-122. The high efficiency paracentesis acquisition with the interactive bone marrow aspiration training system 川北幸平1), 小関義彦2), 上條亜紀3), 荒船龍彦1) Japanese Journal of Transfusion and Cell Therapy 66(2): 361-361, 2020.

O-123. Comparison of manual testing and counting with an automated hematology analyzer for nucleated cells in bone marrow transplants
原口京子1,2), 坂井和巳3), 中川美子1), 渡邉玲1), 大矢未来1), 岡崎江里子1), 森山昌彦1), 石橋小百合1), 佐久間香枝1), 西村加世1), 小室泰司4), 土岐典子5), 大橋一輝5), 田野崎隆二2,6), 奥山美樹1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 362-362, 2020.

O-124. Comparison of the characteristic of the cellular biology of bone marrow blood and the peripheral blood stem cell
皆方大佑1), 藤原慎一郎1,2), 秋山小雪2), 今野雄斗2), 長尾里桃2), 武井生成2), 秋山友子2), 大槻郁子2), 進藤聖子2), 尾島佐恵子2), 小林美佳2), 菅野直子2), 岸野光司2), 室井一男1,2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 362-362, 2020.

O-125. About granulocytes sampling using the Hydroxyethylated starch, an attempt of the collect rate improvement with the citric acid preparation to mix
木村真衣子1,2), 藤井敬子2,3), 小林宏紀2), 近藤匠1,2), 松田真幸1,2), 池川俊太郎1,2), 清家圭介1,2), 三道康永1,2), 高木尚江1,4), 閘結稀1), 池田亮1), 浅野尚美1), 小郷博昭1), 藤井伸治1,2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 363-363, 2020.

	O-126. About the effect that a factor on the recipient side particularly age gives to quantity of transfusion in the cord-blood transplant 岩間幹一, 塚田端夫, 松井茉里奈, 梶原耕一, 山田一成, 幸道秀樹, 香西康司 Japanese Journal of Transfusion and Cell Therapy 66(2): 363-363, 2020.

O-128. About lymphocytes rebuilding after the allogeneic hematopoietic stem cell transplantation and relations of the donor age
但馬史人1), 足立康二1), 西尾崇矢2), 田澤千明2), 浜田のぞみ1), 山崎千穂1), 野口綾1), 橋本ひろみ1), 柴原萌黄1), 的場加名1), 矢田丞1), 新田ひとみ1), 鈴宮淳司3)
Japanese Journal of Transfusion and Cell Therapy 66(2): 364-364, 2020.

O-129. Transplant (fully allotransplant) from a related donor varying in both HLA for the recurrence after the transplant together
池亀和博1), 海田勝仁1), 福永景子1), 大杉夕子1), 吉原享子1), 吉原哲1), 石井慎一2), 藤野聡司3), 山下鷹也4), 真弓あずさ5), 丸山聡6), 寺本昌弘7), 井上貴之1), 岡田昌也1), 玉置広哉1), 小川啓恭1), 藤盛好啓1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 365-365, 2020.

	O-130. subgenotype of the hepatitis E viral strain derived from Hokkaido volunteer blood donor and regional characteristic 飯田樹里1), 金城果歩1,2,3), 小林悠1), 坂田秀勝1), 松林圭二2), 佐藤進一郎1), 生田克哉3), 山本哲3), 池田久實3), 紀野修一1) Japanese Journal of Transfusion and Cell Therapy 66(2): 365-365, 2020.

	O-131. Comparison of the amplification reagent in the multiplex real-time RT-PCR measurement for genotypical quick differentiation of the hepatitis E virus 小林悠1), 飯田樹里1), 坂田秀勝1), 佐藤進一郎1), 生田克哉2), 山本哲2), 池田久實2), 紀野修一1) Japanese Journal of Transfusion and Cell Therapy 66(2): 366-366, 2020.

O-132. Example that caused hepatic dysfunction due to the HEV infection derived from transfusion preparation after the allogeneic hematopoietic stem cell transplantation
山崎理絵1), 森毅彦2), 加藤淳2), 長谷川雄一3), 櫻井政寿2), 中山瞳2), 五十嵐靖浩1), 松橋博子1), 鳥海綾子1), 浅尾裕美子1), 桑原靖子1), 女ケ沢遥1), 弥永侑子1), 上村知恵1), 岡本真一郎2), 田野崎隆二1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 366-366, 2020.

	O-133. Safe improvement of the blood for the transfusion judging from the situation of the infection related to transfusion in the community hospital 稲葉頌一, 佐藤博行, 坂本久浩 Japanese Journal of Transfusion and Cell Therapy 66(2): 367-367, 2020.

	O-134. About the window period in testing for TLV-1 infection 相良康子, 中村仁美, 山本翠, 古賀智英, 宮本彰, 島村益広, 松山博之, 入田和男 Japanese Journal of Transfusion and Cell Therapy 66(2): 367-367, 2020.

	O-135. Development of the pathogen inactivation method of the red blood cell preparation 岡田義昭 Japanese Journal of Transfusion and Cell Therapy 66(2): 368-368, 2020.

	O-136. Analysis of the allergic reaction in the transfusion second response 小松真由美1), 野間慎尋1), 廣瀬祥子1), 栗田絵美1), 山岡愛子1), 矢内綾佳1), 柏原真由1), 野崎晶太1), 石井綾華1), 井上暢子2), 石田誠子2), 山崎尚也2), 藤井輝久2) Japanese Journal of Transfusion and Cell Therapy 66(2): 368-368, 2020.

	O-137. Examination of the onset time for allergic transfusion reaction and nonhemolytic febrile reaction 小林伶1), 柳沢龍1,2), 小嶋俊介2), 本田孝行1,2,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 369-369, 2020.

	O-138. Analysis of the blood transfusion reaction report in our hospital 中林恭子, 木下明美, 緒方康貴, 岡本好雄, 槍澤大樹, 菅野仁 Japanese Journal of Transfusion and Cell Therapy 66(2): 369-369, 2020.

	O-139. Sensitivity, specificity of the passiveness basophils activated study for allergic blood transfusion reaction investigations 保井一太1), 松山宣樹1), 上山敦子2), 岡一彦3), 今田和典3), 加藤栄史4), 木村貴文1), 瀧原義宏1), 平山文也1) Japanese Journal of Transfusion and Cell Therapy 66(2): 370-370, 2020.

O-140. The current situation of the iron chelate therapy for a large quantity of erythrocyte transfusion patients with a blood-forming organ disease
横濱章彦1), 奥山美樹2), 上田恭典3), 伊藤真澄4), 藤原慎一郎5,10), 長井一浩6), 荒川仁香7), 牧田雅典8), 宮崎浩二9), 池田和彦10), 紀野修一10), 田中朝志10), 長谷川雄一10), 藤野恵三10), 牧野茂義10), 松本真弓10), 竹下明裕10), 室井一男10)
Japanese Journal of Transfusion and Cell Therapy 66(2): 370-370, 2020.

	O-141. Attempt of the results of the O-type red blood cell liquid storage in one obstetrics small scale medical institution and the storage operation by the ATR 藤田浩1), 三根堂2), 堀真樹2), 永井泰3), 田中朝志4) Japanese Journal of Transfusion and Cell Therapy 66(2): 371-371, 2020.

	O-142. Examination of the transfusion 11 case with the Ogasawara blood rotation system 亀崎真1), 内藤咲恵1), 松平慶2), 植田美帆2), 飴谷利江子3), 名倉豊4), 岡崎仁4), 寺谷美雪5), 藤田浩5) Japanese Journal of Transfusion and Cell Therapy 66(2): 371-371, 2020.

O-143. Study of the operation that multiple cooperation medical institutions support for use of blood products in the critical care center of Amami blood rotation, the remote island
大木浩1,8), 竹原哲彦2,8), 西迫裕昭2,8), 宮下幸一郎2,8), 寺野玉枝2,8), 花牟禮豊3,8), 奥沙織3), 大塚眞紀4,8), 森千奈美4), 宮園卓宜5,8), 藤山裕輝5), 中島彩乃5), 原純1), 清武貴子1), 園田大敬1), 中野秀人1), 義永文一6,8), 原口安江7), 古川良尚7,8), 田中朝志9)
Japanese Journal of Transfusion and Cell Therapy 66(2): 372-372, 2020.

	O-144. Operation of the blood transport system ATR in our hospital and the evaluation 多田直記1), 大澤俊也1), 中村有紀2), 大久保光夫1,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 372-372, 2020.

	O-145. Transfusion in front of the hospital to the emergency patient by doctor copter which carried blood transport system ATR700 岩尾憲明1,2), 土屋明実2), 白須智奈美2), 伊藤彩花2), 片山瑞希2), 小池道明1) Japanese Journal of Transfusion and Cell Therapy 66(2): 373-373, 2020.

	O-146. Introduction and operation of the blood transport system ATR in the extensive trauma center 石原智子1), 兒玉るみ1), 足立絵里加1), 定方智美1), 藤原宇志1), 三島清司1), 井上政弥2), 竹谷健2), 矢野彰三1) Japanese Journal of Transfusion and Cell Therapy 66(2): 373-373, 2020.

	P-1. About inflection of the use of blood products fact-finding in Kochi (the second report) 佐竹小百合1,7), 北川晋士2,7), 宮地秀典3,7), 石本倫子4,7), 西満子5,7), 山崎美香1,7), 栄枝弘司6,7), 砥谷和人5,7), 溝渕樹1,7,8) Japanese Journal of Transfusion and Cell Therapy 66(2): 377-377, 2020.

	P-2. Medical institution cooperation - transfusion summit in Kochi ... through the meeting meeting 北川晋士1,6), 石本倫子2,6), 西内律雄2,6), 今村潤3,6), 河野威1,6), 畠中豊人4,6), 溝渕樹5,6) Japanese Journal of Transfusion and Cell Therapy 66(2): 377-377, 2020.

	P-3. Effect of the exchange of opinions by the institution visit activity of the Nagano transfusion therapy sectional meeting in our hospital 原博明1), 小嶋俊介2), 竹野祐希1), 中野聡1), 宮島誠3), 下条久志4), 矢ヶ崎宏紀5) Japanese Journal of Transfusion and Cell Therapy 66(2): 378-378, 2020.

P-4. Activity report with the Gifu combination transfusion therapy Committee "transfusion laboratory technician network consultation support system"
森本剛史1), 伊藤裕子2), 福岡玲3), 鳥居知美2), 燈明奈緒4), 樋口布抄子5), 帖佐光洋6), 八木良仁7), 植田米男8), 高橋健9), 林勝知8), 小杉浩史10)
Japanese Journal of Transfusion and Cell Therapy 66(2): 378-378, 2020.

P-5. Effect of the observer dispatch activity to the each institution transfusion therapy committee by the sectional meeting specialized in Gifu combination transfusion therapy Committee
鳥居知美1,9), 森本剛史2,9), 伊藤裕子1,9), 八木良仁3,9), 福岡玲4,9), 黒木泰則5,9), 高橋健6,9), 林勝知7,9), 小杉浩史1,8,9)
Japanese Journal of Transfusion and Cell Therapy 66(2): 379-379, 2020.

P-6. The current situation and problem of the prefecture activity about the role of the nurse in the transfusion team approach in medical care system
平野美佳1), 森美恵子1,10), 川本みな実2), 成瀬昌代2,10), 下村真由美3), 中永徳子3,10), 大野里美4,10), 脇坂志保5,10), 高木麻姫子6,10), 鳥居知美7,10), 伊藤裕子7,10), 岡田和智8,10), 植田米男9,10), 小杉浩史7,10)
Japanese Journal of Transfusion and Cell Therapy 66(2): 379-379, 2020.

	P-7. Efforts to the blood products self-sufficiency in the Tohoku block 中川國利, 柴崎至, 早坂勤, 田村昭彦, 築館和良 Japanese Journal of Transfusion and Cell Therapy 66(2): 380-380, 2020.

	P-8. Inspection - of effect - vasovagal reflex (VVR) occurrence of supplementary diet protective efficacy in blood donation settings 橋爪龍磨, 近藤学, 秋山眞由美, 相良智則, 難波寛子, 國井典子, 澤村佳宏, 石丸文彦, 磯則和, 加藤恒生 Japanese Journal of Transfusion and Cell Therapy 66(2): 380-380, 2020.

	P-9. Correspondence for inquiry and them from a medical institution to the blood center about the transfusion-associated examination 國井華子, 寺田亨, 吉田斉, 阿部真, 面川進 Japanese Journal of Transfusion and Cell Therapy 66(2): 381-381, 2020.

	P-10. Volunteer blood donor prediction 20 years after we saw it from dynamic of population statistics of Yamaguchi 稲葉頌一1), 佐藤博行1), 坂本久浩1), 吉山里美2), 藤井輝允2) Japanese Journal of Transfusion and Cell Therapy 66(2): 381-381, 2020.

P-11. About result of the preparation self-support improvement measures business (hepatitis B vaccine additional inoculation program) special in 2018
國米修平1), 本山裕太1), 杉山朋邦1), 瀧川正弘1), 石丸健1), 松林圭二1), 大久保理恵1,4), 西田一雄3), 保坂勇一1), 村井利文1), 紀野修一2), 高橋孝喜1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 382-382, 2020.

	P-12. Conduct the orientation by the nurse at department of transfusion before the peripheral blood stem cell sampling 横手恵子1), 岩田幸枝1), 丸橋隆行1), 齋藤京子1), 栗原愛子2), 福田沙也加1), 菊池美江1), 茂木真理1), 住谷静香1), 関上智美1), 横濱章彦1) Japanese Journal of Transfusion and Cell Therapy 66(2): 382-382, 2020.

	P-13. The intractable multiple myeloma that the stem cell sampling with the bortezomib + cyclophosphamide massive dose therapy was effective after the long-term treatment containing lenalidomide 中島潤1,2), 榊智佳2), 北之園英明2), 小林裕児2), 加藤丈晴2), 吉田真一郎2) Japanese Journal of Transfusion and Cell Therapy 66(2): 383-383, 2020.

	P-14. Future problem accompanied with usefulness of the HPC measurement in the peripheral blood stem cell sampling and the CD34-positive cells inside the hospital start of measurement 旭千佳1), 長能奈央1), 三浦美里1), 相馬史典1), 木元宏弥1), 越高正広1), 武田晃典1), 柿木康孝2) Japanese Journal of Transfusion and Cell Therapy 66(2): 383-383, 2020.

	P-15. Examination of the self-peripheral blood stem cell sampling in the first multiple myeloma in the single institution 谷本一樹, 河野一郎, 坂本佳治, 山中育未, 平安山英穂 Japanese Journal of Transfusion and Cell Therapy 66(2): 384-384, 2020.

	P-16. Significance of the plerixafor introduction for the case having poor remarkable hematopoietic progenitor cells mobilization 松井勇二郎, 清田麻里奈, 荒川千夏, 城成加奈, 和佐野智美 Japanese Journal of Transfusion and Cell Therapy 66(2): 384-384, 2020.

	P-17. Change of the number of the autologous peripheral blood stem cell sampling by the use of Plerixafor in our hospital 藤原大也1), 中川智博1), 平内洋一1), 角南一貴2) Japanese Journal of Transfusion and Cell Therapy 66(2): 385-385, 2020.

P-18. Autologous peripheral blood stem cell sampling with the Plerixafor administration and the day before CD34-positive cytometric importance
中村裕樹1), 大久保光夫2,3), 降田喜昭1), 長谷川梨絵1), 鞠子文香1), 岩田美沙子1), 市川佳世子1), 鴇田果秀1), 大澤俊也2), 多田直記2), 澤田朝寛2), 大坂顯通1,3)
Japanese Journal of Transfusion and Cell Therapy 66(2): 385-385, 2020.

P-19. One patient who raised serious passenger Lymphocyte Syndrome after the allogeneic peripheral blood hematopoietic stem cell transplantation
力丸峻也1), 高野希美1), 川畑絹代1), 小野智1), 皆川敬治1,2), 渡邉万央1), 佐々木睦美1), 高橋沙樹1), 奥津美穂1,3), 安田広康2), 木村哲4), 池添隆之4), 池田和彦1,2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 386-386, 2020.

	P-20. It is one patient of the diffuse large-cell B-cell lymphoma who had autoimmune haemolytic anaemias at the recurrence 鈴木弘太郎, 清水里恵, 山家佑介, 佐橋里美, 岩井雅則 Japanese Journal of Transfusion and Cell Therapy 66(2): 386-386, 2020.

	P-21. We look at the rear of the peripheral blood stem cell management method in our hospital and examine a mark 目黒冬樹1), 赤木智昭2), 星合桂太1), 冨士井孝彦3), 太田健3), 舛甚義幸1), 久保恒明3), 北澤淳一1) Japanese Journal of Transfusion and Cell Therapy 66(2): 387-387, 2020.

	P-22. An evaluation of the peripheral blood stem cell cryopreservation and diachronic effect 下山治香1,2), 福吉葉子1,2), 吉田朝子1,2), 石原綾子1,2), 崎田紫織1,2), 内場光浩2,4), 横山俊朗1,2), 松井啓隆1,3), 米村雄士2,4), 松岡雅雄2,4) Japanese Journal of Transfusion and Cell Therapy 66(2): 387-387, 2020.

	P-23. Infusion CD34 counts in the autologous peripheral blood stem cell transplantation and analysis of the survival period 野坂生郷1), 高木あゆ美1), 井上明威1), 立津央1), 米村雄士2), 松岡雅雄1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 388-388, 2020.

	P-24. It is HLA-mismatched allogeneic hematopoietic stem cell transplantation using the cyclophosphamide after the transplant for donor-specific antiHLA antigens strong positive patients 岩井俊樹1,2), 栗山幸大2), 内山人二1,2), 森下加代子1), 布施沙也香3), 多気秀和3), 宮越真由美4) Japanese Journal of Transfusion and Cell Therapy 66(2): 388-388, 2020.

	P-25. Examination about the change of the blood grouping results of the ABO incompatibility same kind hematopoietic stem cell transplantation case 濱野京子1), 新井康之1,2), 万木紀美子1), 菱田理恵1), 澁谷江里香1), 西山有紀子1), 高折晃史2), 平位秀世1), 長尾美紀1) Japanese Journal of Transfusion and Cell Therapy 66(2): 389-389, 2020.

	P-26. Examination of the transfusion consumption of the ABO incompatibility elderly people cord-blood transplant in our center 土田紗貴1,2), 松田美弥子1), 阿部真愛1), 小菅隆雄1), 谷田部元野1), 白石弥生3), 奈良岡綾子3), 齊藤輔3), 小倉和外3), 小林寿美子1,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 389-389, 2020.

	P-27. Results of the allograft for acute myeloid leukemia in our hospital 山崎聡子1,2), 小島直美1), 高山信之3), 大西宏明1,2), 渡邊卓1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 390-390, 2020.

	P-28. We look at the CD34-positive cytometric rear in the allogeneic marrow transplantation and examine a mark 木田実里1), 柴田貴太1), 岡崎美彩乃1), 佐々木富美1), 禿蘭子1), 松原憲幸2), 月安啓一郎2), 安藤誠2), 小塚麻紀2), 重松明男3), 太田秀一3), 佐藤繁樹1) Japanese Journal of Transfusion and Cell Therapy 66(2): 390-390, 2020.

	P-29. Reevaluation of the HLA test for antibodies for the hematopoietic stem cell transplantation (SCT) patients of our hospital enforcement 小山暁史1), 杉本達哉1), 板垣浩行1), 今泉満明1), 中塩屋千絵1), 土田文子1), 櫻井朋美1), 武井美恵子1), 池田瞳1), 関口千織1), 豊崎誠子2) Japanese Journal of Transfusion and Cell Therapy 66(2): 391-391, 2020.

	P-30. It is a lymphoproliferative disorder after the EB virus-related transplant merged after the brain death both lungs transplant after the allogeneic hematopoietic stem cell transplantation 星野匠臣, 松村郁子, 飯野宏允, 初見菜穂子, 高田覚, 佐倉徹 Japanese Journal of Transfusion and Cell Therapy 66(2): 391-391, 2020.

	P-31. Fact-finding (interim report) of the at-home transfusion in Japan 田中朝志1), 北澤淳一2), 石田明3), 奥田誠4), 高梨一夫5), 藤田浩6), 長井一浩7) Japanese Journal of Transfusion and Cell Therapy 66(2): 392-392, 2020.

P-32. From the current situation and problem questionnaire results of the at-home transfusion in Ishikawa
二木敏彦1,10), 佐藤英洋2,10), 重山郁子3,10), 西村泰行4,10), 川上麻里絵5,10), 飯島有加10), 橋本哲夫10), 齊藤正典6,10), 中村定生7,10), 塩原信太郎8,10), 菊地修一9,10), 川端浩5,10), 山崎宏人2,10)
Japanese Journal of Transfusion and Cell Therapy 66(2): 392-392, 2020.

P-33. About the actual situation of the foreign transfusion in Toyama
渡部真喜1,2), 安村敏1), 彼谷裕康1), 道野淳子1), 寺崎靖1), 黒川敏郎1), 経田克則1), 又野禎也1), 冨田章代1), 山本由加里1), 山田智恵美1), 浜田麻由子1), 南部重一1), 大下恵1), 二正寺宏美1), 川田惠子1,2), 横川博1,2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 393-393, 2020.

	P-34. Treatment examination of the cancer disease non-cancer disease that we transfused at-home in senior Popes 辻川昭仁1), 山本健2) Japanese Journal of Transfusion and Cell Therapy 66(2): 393-393, 2020.

	P-35. The actual situation of outside Parliament transfusion in our hospital and the at-home transfusion and future development 深堀道俊1), 原口勝2) Japanese Journal of Transfusion and Cell Therapy 66(2): 394-394, 2020.

	P-36. Approach of the at-home transfusion 荒木竜哉1), 木下紗綾1), 吉澤天馬1), 村下ちなつ1), 實原正明1), 原克実2), 塚原孝典3), 長沼邦明3) Japanese Journal of Transfusion and Cell Therapy 66(2): 394-394, 2020.

	P-37. Study operation (the second report) of the portable type blood refrigerator in the at-home transfusion 藤田浩1), 三根堂2), 大橋晃太3), 太田祥一4), 英裕雄5), 石永裕司6), 都能克博7), 田中朝志8) Japanese Journal of Transfusion and Cell Therapy 66(2): 395-395, 2020.

	P-38. At-home transfusion patients observation and heartbeat change variable analysis with the remote vital monitor 西川彰則1,2,3,4), 蒸野寿紀3), 田村志宣3), 赤坂浩司4), 園木孝志1,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 395-395, 2020.

P-39. About the construction of the transfusion system for the transplant in our hospital and the effect
宮園卓宜1), 中島彩乃2,3,4), 藤山裕輝2,3,4), 新屋果蓮1,3), 小田原千里1,3), 牧野桃子2,3), 兼石知香2,3), 久保友恵4), 小田原淳1), 中野伸亮1), 高塚祥芝1), 宇都宮與1), 帆北修一3,5)
Japanese Journal of Transfusion and Cell Therapy 66(2): 396-396, 2020.

	P-40. Efforts of the transfusion management system introduction using "patients security guide (transfusion edition) Ver.2.0 of the JAHIS medical information system" 岩木啓太, 成田香魚子, 伊藤智啓, 細川真梨, 郷野辰幸, 石岡夏子, 阿部真知子, 佐藤裕子, 関修, 藤原実名美, 張替秀郎 Japanese Journal of Transfusion and Cell Therapy 66(2): 396-396, 2020.

	P-41. About the transfusion administrative work accompanied with the hospital move 水野友靖1), 関芳恵1), 立花智子1), 岩田晃裕1), 宮木祐輝1), 武田明果2) Japanese Journal of Transfusion and Cell Therapy 66(2): 397-397, 2020.

	P-42. About transfusion-associated blunder, incident count in Kochi 西満子1,9), 北川晋士2,9), 宮地秀典3,9), 檜垣智也4,9), 森綾5,9), 石本倫子6,9), 前田智子7,9), 古井郁恵8,9) Japanese Journal of Transfusion and Cell Therapy 66(2): 397-397, 2020.

	P-43. Examination about the effect on blood products by a cooling box supercooling 江口政志1), 冨松優太1), 羽根田亜衣1), 丸石桃花1), 入江明美1), 片山徹1), 安井昌博1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 398-398, 2020.

	P-44. About the current situation of the blood products irradiation equipment of our hospital and future correspondence 篠原茂1), 山川朋世1), 小林歩1), 神長亮平1), 藤田友香1), 池田紀彦1), 高柳玲子1), 簗瀬直樹1), 高橋渉1,2), 三谷絹子1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 398-398, 2020.

	P-45. Problem in the transfusion education of our hospital 上野山量也1), 谷口亜希子1), 岡智子2), 平松美保3), 岡本さゆり3), 東由紀奈1) Japanese Journal of Transfusion and Cell Therapy 66(2): 399-399, 2020.

P-46. 1 case that showed panagglutination by exposure of the T antigen due to the pneumococcal infection
森文香, 上村知恵, 五十嵐靖浩, 松橋博子, 浅尾裕美子, 桑原靖子, 小池留以, 女ケ沢遥, 弥永侑子, 清水翔太, 藤村亮介, 森遥, 斎藤俊一, 橋本亮佑, 滝澤輝弥, 藤森祐多, 山崎理絵, 田野崎隆二
Japanese Journal of Transfusion and Cell Therapy 66(2): 399-399, 2020.

	P-47. The children who produced drug autoantibody antie which had origin-related possibilities 福田善久1), 常盤夏子1), 安部朋子1), 児玉祥彦2), 石川友一2), 佐川浩一2) Japanese Journal of Transfusion and Cell Therapy 66(2): 400-400, 2020.

	P-48. An example of PCH where there were early diagnosis and safe cold exposure restrictions cancellation by the Donath-Landsteiner antibody detection 中原衣里菜1,2), 藤田浩3), 中原美千代4), 源川結5), 伊東正剛1), 吉橋知邦5), 三澤正弘5), 菅野仁2), 谷ヶ崎博1), 森岡一朗1) Japanese Journal of Transfusion and Cell Therapy 66(2): 400-400, 2020.

	P-49. The diagnosis for five neonatal anaemia in our hospital and treatment strategy 柴徳生1,2), 瀧澤かすみ1), 黒沢英里1), 小峰弘美1), 岩上薫1), 原田佐保1), 飯塚敦広2), 吉富誠弘2), 佐々木康二2), 釼持孝博2), 魚住梓2), 竹内正宣2), 伊藤秀一2) Japanese Journal of Transfusion and Cell Therapy 66(2): 401-401, 2020.

	P-50. Examination of initial diagnosis hematopoietic efficacy and the quantity of necessary transfusion in the advanced neuroblastoma 紺野沙織1,2,3), 柳沢龍1,3), 久保田紀子4), 坂下一夫5), 戸塚実1,4), 本田孝行2) Japanese Journal of Transfusion and Cell Therapy 66(2): 401-401, 2020.

	P-51. Blood products inside the hospital division systems construction and the current situation of neonates, children 山川朋世1), 櫻井梓帆里1), 小林歩1), 神長亮平1), 藤田友香1), 池田紀彦1), 高柳玲子1), 簗瀬直樹1), 篠原茂1), 高橋渉1,2), 鈴村宏3), 三谷絹子1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 402-402, 2020.

	P-52. It is 2015 certification acquisition ISO9001 in umbilical blood, the umbilical cord bank 高橋敦子1,2), 堀暁子1,2), 山本由紀1,2), 三春祐太1,2), 尾上和夫1,2), 長村登紀子1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 402-402, 2020.

	P-53. Examination of the clinical examination that can predict a blood removal delinquent resulting during ingredient drawing blood 紺野沙織1,2), 柳沢龍1), 元木倫子3), 本田孝行2), 下平滋隆4) Japanese Journal of Transfusion and Cell Therapy 66(2): 403-403, 2020.

	P-54. Change of the indoleamine-2,3-dioxygenase (IDO) association material in GVHD treatment using the mesenchyma system stem cell 石田秀和1,3), 北川順一1,2), 二宮空暢1,2), 浅野栄太1), 日比由佳1), 谷口寿章1), 大橋葉津希1), 佐藤弦士朗1), 山本康子3), 齋藤邦明3) Japanese Journal of Transfusion and Cell Therapy 66(2): 403-403, 2020.

	P-55. Of the self-lymphocytes apheresis sampling to use for CAR-T therapy, actually 松浦健1), 小笠原亮太1), 佐々木俊一1), 島貫美和子3), 岩木啓太2), 阿部真知子2), 藤原実名美2), 張替秀郎2) Japanese Journal of Transfusion and Cell Therapy 66(2): 404-404, 2020.

	P-56. Present situation and problems of cell treatment of mononuclear cells for Tisagen lecleucel (Kymriah) in this hospital. 丹羽紀実, 松井恵子, 中川陽子, 澁谷江里香, 新井康之, 平位秀世, 西山有紀子, 長尾美紀 Japanese Journal of Transfusion and Cell Therapy 66(2): 404-404, 2020.

P-57. As compared with leukapheresis - same kind lymphocytes infusion for CAR-T cellular therapy -
藤井敬子1,2), 木村真衣子2,3), 小林宏紀2), 近藤匠2,3), 松田真幸2,3), 池川俊太郎2,3), 清家圭介2,3), 三道康永2,3), 高木尚江3,4), 閘結稀3), 池田亮3), 浅野尚美3), 小郷博昭3), 藤井伸治2,3)
Japanese Journal of Transfusion and Cell Therapy 66(2): 405-405, 2020.

	P-58. Use experience of the mesenchyma system stem cell preparation derived from human marrow in our hospital and the operation 山岡学, 阿部操, 北睦実, 北畑もも香, 大澤眞輝, 井上まどか, 吉田由香利, 大西修司, 伊藤量基, 野村昌作 Japanese Journal of Transfusion and Cell Therapy 66(2): 405-405, 2020.

	P-59. Examination about the nonspecific response in indirect antiglobulin test (IAT) using 0.2M dithiothreitol processing red blood cell (DTT-Cell) 長谷川浩子, 伊藤道博, 小橋早紀, 田口茉利奈, 仁田亜以乃, 尾坂竜也, 山本浩子, 三川紫緒, 三村尚也, 井関徹 Japanese Journal of Transfusion and Cell Therapy 66(2): 406-406, 2020.

	P-60. Change of our hospital irregularity antibody detection accompanied with all automatic transfusion survey instrument Erytra and Erytra Eflexis introduction 森恵子1,2), 中村由美1), 山路直人1,2), 古川由美3), 角谷有紀3), 森尾志保2,3), 南博仁4), 藤枝敦史2,4), 爾見雅人4), 玉木茂久2,4) Japanese Journal of Transfusion and Cell Therapy 66(2): 406-406, 2020.

	P-61. 2 cases that racked its brains about the judgment of the transfusion test result of patients with emergency conveyed blood disorder by a heart disease merger 坂本京1), 二木由里1), 五十嵐朋子1), 前田かおり1), 星野真理1), 常深あきさ2), 清水勝2) Japanese Journal of Transfusion and Cell Therapy 66(2): 407-407, 2020.

	P-62. 1 case that protein G column was useful for proof of irregularity antibody IgG type antiE to hold continuously 長谷川真弓, 上野華恵, 隅志穂里, 谷山歩, 梅木弥生, 酒井和哉, 松本雅則 Japanese Journal of Transfusion and Cell Therapy 66(2): 407-407, 2020.

	P-63. Inspection for the enzyme method abbreviation of the irregular antibody screening in our hospital 新井裕介, 菅谷紗起, 齋藤寿美, 長谷川雄一 Japanese Journal of Transfusion and Cell Therapy 66(2): 408-408, 2020.

	P-64. Comparison of the indirect antiglobulin test by the difference of the response enhancer 成海仁在, 里部美咲, 西田百合絵, 阪上峻基, 高木景城, 小川章夫, 笹倫郎, 北市正則 Japanese Journal of Transfusion and Cell Therapy 66(2): 408-408, 2020.

	P-65. Investigation before and after the enzyme method abolition in the irregular antibody screening 櫻井朋美1), 梶谷由美子2), 関口千織1), 池田瞳1), 今泉満明1), 小山暁史1), 中塩屋千絵1), 武井美恵子1), 板垣浩行1), 杉本達哉1), 豊崎誠子1) Japanese Journal of Transfusion and Cell Therapy 66(2): 409-409, 2020.

	P-66. Examination to the computer cross match in the small hospital 宮地律子 Japanese Journal of Transfusion and Cell Therapy 66(2): 409-409, 2020.

	P-67. Inspection of the safe transfusion in our hospital irregularity test for antibodies 渡辺隆幸1), 大友颯生1), 阿部柊1), 白谷泰祐1), 星雅子1), 橋本はるみ1), 石井佳代子1), 神林裕行1), 大知里京子2), 作間靖子2) Japanese Journal of Transfusion and Cell Therapy 66(2): 410-410, 2020.

	P-68. Irregular antibody onset frequency in our hospital and the antigen-negative blood ordering situation 小玉諭1,2,3,4), 関村匠1), 天満智佳1), 野渡裕之1), 小堺豊2), 本間淳3), 西村正次3), 石川清臣3), 山本哲3), 紀野修一4) Japanese Journal of Transfusion and Cell Therapy 66(2): 410-410, 2020.

	P-69. The current situation of the irregular antibody screening enzyme method enforcement in our hospital 松本慎二, 河原志帆, 小林瑞紀, 須藤保加, 前田麻衣, 福永祥子, 棚澤敬志, 小林清子, 石田明 Japanese Journal of Transfusion and Cell Therapy 66(2): 411-411, 2020.

P-70. The nonhemolytic blood transfusion reaction occurrence situation in under four months children in the irregular test for antibodies enforcement institution by Micro Typing System after birth
上村正巳, 佐藤美里, 青木寿成, 大木直江, 川合綾野, 松原千秋, 藤本陽子, 渡辺真里, 中田光, 牛木隆志
Japanese Journal of Transfusion and Cell Therapy 66(2): 411-411, 2020.

	P-71. One case that the specificity of the autoantibody changed while it developed autoimmune disease for childhood and repeated hatred remission 山麻衣子, 本田優未, 加藤由佳, 鈴木雅之, 内野富美子, 山田攻, 池淵研二, 岡田義昭 Japanese Journal of Transfusion and Cell Therapy 66(2): 412-412, 2020.

P-72. The case that repeated the delayed hemolytic blood transfusion reaction due to multiple irregularity antibodies in a short term
森遥, 上村知恵, 五十嵐靖浩, 松橋博子, 浅尾裕美子, 桑原靖子, 小池留以, 女ケ沢遥, 弥永侑子, 清水翔太, 藤村亮介, 森文香, 斎藤俊一, 橋本亮佑, 滝澤輝弥, 藤森祐多, 山崎理絵, 田野崎隆二
Japanese Journal of Transfusion and Cell Therapy 66(2): 412-412, 2020.

P-73. 1 case that seemed to show a specific response to K antigen by bacterial infection
小島美有季1), 藤原孝記1,3), 大曽根和子1), 前島理恵子1), 難波宏美1), 永友ひとみ1), 犬塚紀子1), 成田圭吾1), 平山剛士1), 佐久間望1), 佐藤加奈絵1), 田代晴子2), 松本謙介1,2), 白藤尚毅1,2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 413-413, 2020.

	P-74. An example in acknowledgment of antiAnWj 廣田綾子, 内林佐知子, 茂籠弘子, 小室伸子, 湯本浩史, 南口仁志 Japanese Journal of Transfusion and Cell Therapy 66(2): 413-413, 2020.

	P-75. 1 case of the partial E pregnant woman who detected antiE 田代香奈1), 田村典子1), 梶田幸夫1), 今井恵2), 山口景子2), 村岡容子2), 定方久延3), 桑島信4) Japanese Journal of Transfusion and Cell Therapy 66(2): 414-414, 2020.

P-76. 1 case that detected antiLsa in acknowledgment of a difference for a response of PEG-IAT by the difference of the antihuman IgG reagent
平山剛士1), 藤原孝記1,3), 前島理恵子1), 大曽根和子1), 難波宏美1), 永友ひとみ1), 犬塚紀子1), 小島美有季1), 成田圭吾1), 佐久間望1), 佐藤加奈絵1), 鈴木理映子4), 宮崎孔4), 田代晴子2), 松本謙介1,2), 白藤尚毅1,2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 414-414, 2020.

	P-77. 1 case that detected an antibody thought to be antihrs and antiHr 加藤静帆1), 倉科かすみ1), 清水幸代1), 横家信華1), 圓藤ルリ子1), 大西一功1), 常山初江2), 伊佐和美3), 小笠原健一3) Japanese Journal of Transfusion and Cell Therapy 66(2): 415-415, 2020.

	P-78. AntiLW antibody and correspondence of the transfusion that we experienced in our hospital 山田恵美子, 中條晶子, 金田健太郎, 山口美加 Japanese Journal of Transfusion and Cell Therapy 66(2): 415-415, 2020.

	P-79. Practice of the rare blood report 武士俣こずえ1), 関根正英1), 佐藤由来1), 河内珠璃1), 喜多見彩1), 加藤芳浩1), 服部浩全2), 岡本正俊3) Japanese Journal of Transfusion and Cell Therapy 66(2): 416-416, 2020.

	P-80. One patient who became with positive crossmatch by low frequency antigen SUMI in washed red blood cell preparation 牧野博1), 石関彩乃1), 鈴木早紀1), 山本美里1), 沼野井恵1), 石井隆浩1), 小島直美1), 関口久美子1), 高山信之2), 山崎聡子3), 渡邊卓3), 大西宏明1,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 416-416, 2020.

P-81. Basic examination ... of the study - improvement type acid dissociation 2 method of the efficient autoantibody technique and the new elution method
岩原かなえ1), 丸橋隆行1), 須佐梢1), 西本奈津美1), 石川怜依奈1), 横手恵子2), 青山千夏2), 澤田八重子2), 菊池美江2), 福田沙也加2), 吉尾憲人2), 関上智美1), 横濱章彦1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 417-417, 2020.

P-82. Applied ... to the clinical practice of study ... new acid dissociation method of the efficient autoantibody technique
丸橋隆行1), 岩原かなえ1), 石川怜依奈1), 西本奈津美1), 須佐梢1), 関上智美1), 吉尾憲人2), 澤田八重子2), 横手恵子2), 青山千夏2), 菊池美江2), 福田沙也加2), 横濱章彦1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 417-417, 2020.

P-83. Should the adsorption of the autoantibody assume the LISS method a standard? Consideration ... in the case that racked its brains about the identification of ... alloantibody
柏原真由1), 野間慎尋1), 栗田絵美1), 廣瀬祥子1), 小松真由美1), 山岡愛子1), 矢内綾佳1), 野崎晶太1), 石井綾華1), 井上暢子2), 石田誠子2), 山崎尚也2), 藤井輝久2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 418-418, 2020.

	P-84. About the case that a monocytic englobement study was thought to become false-negative by an IgM antibody 楠見智子, 小田晃, 岡島馨人, 奥田久実子, 立山英美, 大谷智司, 瀧原義宏 Japanese Journal of Transfusion and Cell Therapy 66(2): 418-418, 2020.

	P-85. It is a 2 case of the secondary autoimmune hemolytic anemia after the cytomegalovirus initial infection that racked its brains about transfusion correspondence 大吉広朗, 山崎恵美, 吉澤辰一, 高山智美, 阿部正樹, 中田浩二, 塚本公瑠美, 神山祐太郎, 土橋史明, 加藤陽子 Japanese Journal of Transfusion and Cell Therapy 66(2): 419-419, 2020.

	P-86. Comparison of the use situation before and after the expiration date extension of fresh frozen plasma -LR 薮田吉弘1), 加塩奈美1), 加藤祥子1), 平尾進1), 津郷幸子1), 森分智子1), 四木行永1), 石田涼子1), 岩崎真子1), 村田真由美1), 岡田和也1,2), 上田恭典1,2,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 419-419, 2020.

	P-87. About the use of aptitude situation of the fresh frozen plasma of our hospital 尾崎智恵1), 岩崎浩1), 水上かよ子2), 又野禎也1) Japanese Journal of Transfusion and Cell Therapy 66(2): 420-420, 2020.

	P-88. Analysis according to the technique of the red blood cell preparation rate of use in the orthopedics surgery 阿部明宏, 西出いづみ, 坂本紫暢, 佐藤ゆりか, 横田啓 Japanese Journal of Transfusion and Cell Therapy 66(2): 420-420, 2020.

	P-89. Change of the blood products consumption of blood medical patients in our hospital 蟹江由美1), 宮森菜々美1), 川上莉央1), 崎本愛理1), 高崎佳苗1), 臼杵憲祐1), 荒井政和2), 後藤文彦2), 堀内啓2) Japanese Journal of Transfusion and Cell Therapy 66(2): 421-421, 2020.

	P-90. The use situation of blood products in our hospital 関村匠1,2), 小玉諭1), 天満智佳1), 野渡裕之1), 小堺豊2) Japanese Journal of Transfusion and Cell Therapy 66(2): 421-421, 2020.

P-91. About efforts about the proper use of blood products for the transfusion in our hospital
成田圭吾1), 藤原孝記1,3), 前島理恵子1), 大曽根和子1), 難波宏美1), 永友ひとみ1), 犬塚紀子1), 小島美有季1), 平山剛士1), 佐久間望1), 佐藤加奈絵1), 田代晴子2), 松本謙介1,2), 白藤尚毅1,2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 422-422, 2020.

	P-92. Examination for the transfusion management charges proper use addition acquisition 緒方康貴, 岡本好雄, 槍澤大樹, 菅野仁 Japanese Journal of Transfusion and Cell Therapy 66(2): 422-422, 2020.

	P-93. Efforts of the use of blood products situation and waste ratio improvement for the past 8 years 清水咲子1), 武関雄二1), 藤野真治1), 賀古真一2) Japanese Journal of Transfusion and Cell Therapy 66(2): 423-423, 2020.

	P-94. Efforts for the disposal of blood products reduction in our hospital 中務雄介, 高路紗智子, 清水美優紀 Japanese Journal of Transfusion and Cell Therapy 66(2): 423-423, 2020.

	P-95. Result of the T&S promotion for the disposal blood reduction 関戸啓子1), 保坂繭子1), 鎌倉丈紘1), 嘉成孝志1), 鈴木実1), 伊藤利一1), 田中朝志2) Japanese Journal of Transfusion and Cell Therapy 66(2): 424-424, 2020.

	P-96. The use situation and problem of the albumin preparation in our hospital 飯田奈緒1), 大滝紘平1), 高橋明日香1), 宮内万知子1), 藤川潤1), 原美樹子2), 田端淑恵3), 饗庭明子3) Japanese Journal of Transfusion and Cell Therapy 66(2): 424-424, 2020.

	P-97. Effect of promotion and the uniform management of the proper use of the albumin preparation 牟田毅1), 芝昭博1), 上村安美1), 原本圭子1), 井上恭子1), 佐藤浩恵1), 山下みなみ1), 橋本義昭1), 米田登志2), 麻奥英毅3), 岩戸康治2) Japanese Journal of Transfusion and Cell Therapy 66(2): 425-425, 2020.

P-98. For "change of the transfusion duties environment in the medical institution which accepted a business trip lecture" by the questionary survey Aomori combination transfusion therapy Committee activity development
本田昌樹1,2), 立花直樹1,3), 玉井佳子1,4), 田中一人1,4), 柴崎至1,5), 岡本道孝1,6), 坂本忍1,7), 阿部泰文1,5), 西塚和美1,8), 小笠原圭子1,9), 北澤淳一10)
Japanese Journal of Transfusion and Cell Therapy 66(2): 425-425, 2020.

P-99. Future problem ... to hold the transfusion workshop for local nurses by the society authorization nurse society, and to see from ... questionnaire results
今井恵1), 尾沼詩織2), ホプキンズ由貴子3), 齊貴晃3), 松本則子4), 冨賀見公美4), 猪越朋美4), 青木千明4), 中島俊幸5), 伊藤淳5), 丸橋隆行6), 横濱章彦6), 坂倉慶太7), 丸山健一7)
Japanese Journal of Transfusion and Cell Therapy 66(2): 426-426, 2020.

	P-100. Education - for activity report - transfusion therapy after the nurse society authorization, clinical transfusion acquisition 菊地麻里1,2,3,4,5), 岩尾憲明2), 今田春子1), 酒井寛美3), 村岡裕美3), 古谷華菜4), 土屋明実5), 小池道明2) Japanese Journal of Transfusion and Cell Therapy 66(2): 426-426, 2020.

	P-101. Through the training and the questionnaire for activity - nursing assistant who aimed at the safe transfusion therapy - 岩野安希子, 竹田さおり, 西川美沙, 若尾泰弘, 三島賀美, 清水陽子, 松井まり子, 光吉明, 中尾光成 Japanese Journal of Transfusion and Cell Therapy 66(2): 427-427, 2020.

	P-102. Efforts to transfusion education and nurse society authorized transfusion upbringing in the pediatric hospital 浜之上聡1), 鈴木恵美2), 高橋里沙2), 田島正輝3), 神保京子3) Japanese Journal of Transfusion and Cell Therapy 66(2): 427-427, 2020.

	P-103. Effect ... of the general training to efforts - new face nurse of the transfusion education to a nurse in our hospital 中井照代1), 古賀澄江1), 梅木智美1), 鷹野壽代2) Japanese Journal of Transfusion and Cell Therapy 66(2): 428-428, 2020.

	P-104. Clarification of a thought and the behavior of the new face by simulation and the debriefing at the blood transfusion reaction onset 亀岡里沙, 河野真実, 中山綾子 Japanese Journal of Transfusion and Cell Therapy 66(2): 428-428, 2020.

	P-105. For establishment of the transfusion link nurse society and the quality improvement of activity - transfusion nursing of the authorized nurse - 田村将子1), 柴田千春1), 福田直子1), 大薗優子2) Japanese Journal of Transfusion and Cell Therapy 66(2): 429-429, 2020.

P-106. Attempt of the rebuilding of the nurse at Ogaki Municipal Hospital outpatient department section training by the clinical transfusion nurse
二ノ宮絵美1), 古田智子1), 岩崎嘉寿子1), 小島美加1), 中島由美子1), 北野美由紀1), 伊藤麻美1), 長谷川智美1), 久野美穂1), 平野美佳1), 兵頭博美1), 森美恵子1), 田中典子2), 鳥居知美2), 飯田眞理2), 伊藤裕子2), 小杉浩史3)
Japanese Journal of Transfusion and Cell Therapy 66(2): 429-429, 2020.

	P-107. For a clinical transfusion nurse and safe transfusion enforcement way study meeting setup - of - transfusion 神野洋彰, 田中裕士, 藤井都紀世, 竜ひと美 Japanese Journal of Transfusion and Cell Therapy 66(2): 430-430, 2020.

	P-108. It is common knowledge and enforcement ... of ... appearance confirmation for safe transfusion therapy 西川美沙, 岩野安希子, 竹田さおり, 若尾泰弘, 三島賀美, 清水陽子, 松井まり子, 光吉明, 中尾光成 Japanese Journal of Transfusion and Cell Therapy 66(2): 430-430, 2020.

P-109. Attempt of the collection of Ogaki Municipal Hospital scrub nurse transfusion nursing service Q&A documents making
北野美由紀1), 樋口倫代1), 廣瀬貴大1), 寺田美羽1), 古田智子1), 岩崎嘉寿子1), 小島美加1), 中島由美子1), 伊藤麻美1), 長谷川智美1), 久野美穂1), 二ノ宮絵美1), 平野美佳1), 兵頭博美1), 森美恵子1), 鳥居知美2), 伊藤裕子2), 高須昭彦3), 小杉浩史4)
Japanese Journal of Transfusion and Cell Therapy 66(2): 431-431, 2020.

	P-110. Introduction - of the transfusion certification by activity - nurse of society authorization, the clinical transfusion nurse 石井修1), 玉井洋太郎2) Japanese Journal of Transfusion and Cell Therapy 66(2): 431-431, 2020.

	P-111. Improvement of the examination of posttransfusion infection rate of use in our hospital and the efforts 武藤秀治1), 伊藤里彩2), 久保紀子2), 藤本昌子2), 宮脇修一1), 富山順治1) Japanese Journal of Transfusion and Cell Therapy 66(2): 432-432, 2020.

	P-112. Efforts to further improvement of the examination of posttransfusion infection rate of use in our hospital 玉木俊治, 鶴崎辰也 Japanese Journal of Transfusion and Cell Therapy 66(2): 432-432, 2020.

	P-113. About the enforcement situation of the posterior examination of the volunteer blood donor consulting HBV, the HCV infection suspected case from the medical institution 小田彰恭, 高久修司, 茂木聡幸, 後藤直子 Japanese Journal of Transfusion and Cell Therapy 66(2): 433-433, 2020.

	P-114. Analysis of the estrangement specimen in the parvovirus B19-DNA fixed-quantity study 高倉明子, 古居保美, 松林圭二, 佐竹正博 Japanese Journal of Transfusion and Cell Therapy 66(2): 433-433, 2020.

	P-115. We conduct reconfirmation of the appearance by "suspension, ten minutes standstill" of the whole blood platelet preparation 尾上和夫, 阿部結花, 岩澤奈穂, 長村登紀子 Japanese Journal of Transfusion and Cell Therapy 66(2): 434-434, 2020.

	P-116. Attempt of the blood products bacteria pollution detection using the exploratory needle electrospray ionization mass spectrography 古田里佳1), 正木美香子2), 林智也2), 松林圭二1), 佐竹正博1) Japanese Journal of Transfusion and Cell Therapy 66(2): 434-434, 2020.

	P-117. An example in acknowledgment of a delayed-action haemolysis side effect of antiE antic 石関彩乃1), 牧野博1), 鈴木早紀1), 山本美里1), 沼野井恵1), 石井隆浩1), 小島直美1), 関口久美子1), 久松理一2), 山崎聡子1,3), 渡邊卓1,3), 大西宏明1,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 435-435, 2020.

	P-118. 1 case that was able to evade the unidentified blood transfusion reaction that was hemolytic that an irregular antibody was not detected by Rh phenotype same model blood 津崎里奈, 上田真弘, 吉田奈津希, 早川郁代, 椋棒英世, 上月瑶子, 宮田吉晴, 藥師神公和, 川本晋一郎, 南博信 Japanese Journal of Transfusion and Cell Therapy 66(2): 435-435, 2020.

	P-119. About the side effect that is hemolytic that association with antiXga was suggested after the transfusion to a DAT-positive person 相川佳子, 大石裕紀子, 臼井友香里, 伊藤千裕, 白石暁子, 山崎美保, 千葉美沙希, 奥井愛莉, 諏訪志穂子, 大友直樹, 梶原道子 Japanese Journal of Transfusion and Cell Therapy 66(2): 436-436, 2020.

	P-120. Three cases of delayed hemolytic reaction (DHTR) in our hospital 小林美希1), 石原慶子2), 梅村彩2), 熊谷優2), 三輪奈津貴2), 岩井布美子3), 武長章子4), 小笠原友紀4), 籔内由起4), 續木美樹4), 寺田真華4), 丸山桂子4), 片桐香奈子4), 笠井雅信1,2), 内田俊樹1) Japanese Journal of Transfusion and Cell Therapy 66(2): 436-436, 2020.

	P-121. Example that accepted blood transfusion reaction with response enhancer no addition -IAT-negative antiM antibody 佐藤郁恵, 佐々木綾子, 熊谷美香子, 能登谷武, 藤島直仁, 高橋勉 Japanese Journal of Transfusion and Cell Therapy 66(2): 437-437, 2020.

	P-122. Example that developed an anaphylactic shock in the platelet transfusion, and showed basophils activation study positive 伊藤知紗子1), 吉村早耶香2), 小倉謙治3), 笹原洋好2), 湯舟佳子3), 仲里朝周1) Japanese Journal of Transfusion and Cell Therapy 66(2): 437-437, 2020.

	P-123. The current situation of the in-hospital transfusion therapy inspection in our hospital and future problem 渡部和也1,4), 鈴木桂子2), 高橋光子2,4), 渡部千惠2,4), 大野恭子2,4), 鈴木多恵子2,4), 尾崎順子2,4), 村澤宏一2,4), 角田三郎1,3,4), 大田雅嗣3,4) Japanese Journal of Transfusion and Cell Therapy 66(2): 438-438, 2020.

	P-124. An effect and problem of in-hospital inspection system 13 years by Ogaki Municipal Hospital transfusion therapy Committee 高木雄介1,5), 鳥居知美2), 平野美佳3,5), 森美恵子3,5), 清水みゆき2), 田中典子2), 飯田眞理2,5), 伊藤裕子2,5), 岡田和智4,5), 小杉浩史1,2,5) Japanese Journal of Transfusion and Cell Therapy 66(2): 438-438, 2020.

P-125. We work on the transfusion section subcommittee of 6 hospitals attached to the Juntendo University faculty of medicine
増田友紀1), 降田喜昭2), 中村裕樹2), 兼松健也1), 大澤俊也3), 多田直記3), 土屋明実4), 鞠子文香2), 長谷川梨絵2), 山口功子5), 古屋シズ子5), 芝宮かおり5), 山崎恵6), 久野豊6), 大久保光夫3), 大坂顯通7)
Japanese Journal of Transfusion and Cell Therapy 66(2): 439-439, 2020.

	P-126. Transfusion team approach in medical care ... toward transfusion measures project team activity ... appropriate transfusion 溝田瑞恵1,6), 大橋裕子2,6), 加藤祐介3,6), 大西真代3,6), 野口由紀子3,6), 藤井育枝1,6), 倉迫敏明4,6), 平松靖史5,6) Japanese Journal of Transfusion and Cell Therapy 66(2): 439-439, 2020.

	P-127. Improvement of the transfusion education of the nurse in inside the hospital that utilized I&A 松川恵梨子1,2), 山本麻貴2), 川井孝太2), 戸田千恵1), 水野達也1), 匂坂慶紀1), 飛田規3) Japanese Journal of Transfusion and Cell Therapy 66(2): 440-440, 2020.

	P-128. Perform pressure made from the analysis in the - practice information management room about the educational efforts to a nurse for safe transfusion to give by a team; and - 菅沼果南1), 北村憲一2), 福森亮介3), 大濱愛2), 古屋彩2), 松並睦美1) Japanese Journal of Transfusion and Cell Therapy 66(2): 440-440, 2020.

	P-129. It is ... about the current situation and the future when two years passed from activity - start of the transfusion team in our hospital 三島賀美, 松井まり子, 清水陽子, 岩野安希子, 西川美沙, 竹田さおり, 若尾泰弘, 光吉明, 中尾光成 Japanese Journal of Transfusion and Cell Therapy 66(2): 441-441, 2020.

	P-130. Activity ... of proper use ... "transfusion measures project team" wrestling by a team 大橋裕子1,6), 溝田瑞恵2,6), 加藤祐介3,6), 大西真代3,6), 野口由紀子3,6), 藤井育枝2,6), 倉迫敏明4,6), 平松靖史5,6) Japanese Journal of Transfusion and Cell Therapy 66(2): 441-441, 2020.

	P-131. Participation of the blood center medical representative in transfusion therapy Committee 中山良輔, 山田聡美, 福田有紗, 徳永好美 Japanese Journal of Transfusion and Cell Therapy 66(2): 442-442, 2020.

	P-132. Efforts of the in-hospital education for physician nurses for safe transfusion therapy in our hospital 會田砂良, 名倉豊, 中村潤子, 川端みちる, 澤田良子, 廣瀬有香, 奥谷美紅, 山崎翔, 池田敏之, 岡崎仁 Japanese Journal of Transfusion and Cell Therapy 66(2): 442-442, 2020.

	P-133. Efforts for safe transfusion duties out of the time 市邉明美1), 吉川美代子1), 石和田萌笑1), 大谷哲司1), 中矢桂子2), 徳永裕彦1) Japanese Journal of Transfusion and Cell Therapy 66(2): 443-443, 2020.

	P-134. Efforts aiming at the training participation rate improvement for personnels 石井洋子, 三末高央 Japanese Journal of Transfusion and Cell Therapy 66(2): 443-443, 2020.

	P-135. The current situation of the urgent O-type erythrocyte transfusion in our center 谷村憲洋, 今里勝紀, 舟谷正純, 徳山純嗣 Japanese Journal of Transfusion and Cell Therapy 66(2): 444-444, 2020.

	P-136. About the current situation of the urgent O-type erythrocyte transfusion in our hospital 横沢亮1), 安部川裕美1), 小林重己1), 中村和之1), 平澤晃2), 佐藤忠嗣1) Japanese Journal of Transfusion and Cell Therapy 66(2): 444-444, 2020.

	P-137. One patient whom we urgently transfused RhD-positive blood to because of unexpected bleeding during the surgery of the RhD-negative patients 武井生成, 岸野光司, 秋山小雪, 今野雄斗, 長尾里桃, 秋山友子, 大槻郁子, 進藤聖子, 尾島佐恵子, 小林美佳, 菅野直子, 室井一男 Japanese Journal of Transfusion and Cell Therapy 66(2): 445-445, 2020.

	P-138. Case report of the emergency incompatible blood transfusion 大谷彩恵1), 間由紀1), 中原美千代1), 浅香祐幸1), 寺谷美雪1), 西村滋子2), 藤田浩2) Japanese Journal of Transfusion and Cell Therapy 66(2): 445-445, 2020.

	P-139. A problem and efforts of the paper operation in the urgent transfusion of our hospital 清水武二1), 中村拓司1), 山本晃2) Japanese Journal of Transfusion and Cell Therapy 66(2): 446-446, 2020.

	P-140. The use actual situation by urgent transfusion - lifesaving first aid in the local core hospital 高木悠輔1), 鈴木久仁子1), 藤田沙耶花1), 加藤ななみ1), 渡邊有里耶1), 高木佳耶1), 岩田智久1), 九里孝雄2,3) Japanese Journal of Transfusion and Cell Therapy 66(2): 446-446, 2020.

P-141. It is efforts ... of the practice type training using the manual of ... check list pattern for steady supply of the urgent transfusion and correspondence ability improvement
大濱愛1), 池本早希1), 竹中友希1), 新川雄士1), 河並香央理1), 長谷川健二1), 畑久勝1), 山本孝吉1), 北村憲一2), 古屋彩2)
Japanese Journal of Transfusion and Cell Therapy 66(2): 447-447, 2020.

	P-142. Operation of the emergency department reserve red blood cell preparation in our hospital 高橋沙樹1), 力丸峻也1), 佐々木睦美1), 渡邉万央1), 山田舞衣子1), 皆川敬治1), 高野希美1), 奥津美穂1,2), 小野智1), 三浦里織1,3), 川畑絹代1), 三村耕作1,4), 鈴木剛5), 池田和彦1) Japanese Journal of Transfusion and Cell Therapy 66(2): 447-447, 2020.

	P-143. The blood grouping enforcement situation and refinement before invasive measures 清水直美, 鈴木大夢, 蓮沼秀和, 石田智子, 岩下洋一 Japanese Journal of Transfusion and Cell Therapy 66(2): 448-448, 2020.

	P-144. The disaster training using the action card and future problem 前田岳宏, 井手大輔, 前田朋子, 地守慶亮, 中野勝彦, 福島靖幸, 川野亜美, 椿本祐子, 藤田往子, 金光靖, 芦田隆司 Japanese Journal of Transfusion and Cell Therapy 66(2): 448-448, 2020.

	P-145. 1 case that used atypical blood with the massive bleeding in the operation in large quantities 古川良尚1), 橋ノ口寛仁2), 江口奈津希1), 櫛山歩1), 中島篤人2), 濱田平一郎1), 原口安江1), 外室喜英1), 宮元珠華1), 舞木弘幸1), 大迫洋一3), 吉野裕史3), 鑪野秀一3) Japanese Journal of Transfusion and Cell Therapy 66(2): 449-449, 2020.

	P-146. About a transfusion regime at massive bleeding 山本匠, 宮下徹也, 長峯宏美, 瀧澤かすみ, 原田佐保, 上條亜紀 Japanese Journal of Transfusion and Cell Therapy 66(2): 449-449, 2020.

	P-147. - important preparation of the critical bleeding at the hospital attached to the Yamagata University faculty of medicine for preparations and the first report and monitoring of results - emergency department 奈良崎正俊, 石山裕子, 柴田早紀, 大塚那奈, 加藤裕一, 東梅友美, 石澤賢一 Japanese Journal of Transfusion and Cell Therapy 66(2): 450-450, 2020.

	P-148. Enforcement report of "the operating room critical bleeding simulation" in our hospital 舟崎史織1), 伊藤公人1,2), 久野敬子1), 稲生千絵美1), 廣田優美1) Japanese Journal of Transfusion and Cell Therapy 66(2): 450-450, 2020.

	P-149. An example of the administration to the fibrinogen preparation storage system in the distant place remote island medical office and mass genital bleeding 松平慶1), 山並航1), 植田美帆1), 森純子1), 内藤咲恵2), 亀崎真2), 橋本洋子1,2), 寺谷美雪3), 名倉豊4), 岡崎仁4), 藤田浩3) Japanese Journal of Transfusion and Cell Therapy 66(2): 451-451, 2020.

	P-150. Usefulness of the IPF (the juvenile platelet ratio) examination in the thrombocytopenia prediction of the patients with blood disorder 谷口容1,2), 山口孝一1), 藤野匡2), 吉尾伸之3), 高見昭良4), 森下英理子1,5) Japanese Journal of Transfusion and Cell Therapy 66(2): 451-451, 2020.

	P-151. One case that we investigated the cause for the shock patients due to severe anemia quickly in an examination room and were able to save 藤野匡1), 谷口容1,2), 吉尾伸之3) Japanese Journal of Transfusion and Cell Therapy 66(2): 452-452, 2020.

	P-152. A case of autoimmune hemolytic anemia due to anti-D specific warm autoantibody after treatment for malignant lymphoma 岡智子1), 平松美保2), 岡本さゆり2), 松岡徳登2), 直川正治1), 池田紀男2) Japanese Journal of Transfusion and Cell Therapy 66(2): 452-452, 2020.

	P-153. Effect to be transfusion of the myelodysplastic syndrome that azacitidine made the white blood-dependent, and to give 塚田端夫, 松井茉里奈, 岩間幹一, 梶原耕一, 山田一成, 幸道秀樹, 香西康司 Japanese Journal of Transfusion and Cell Therapy 66(2): 453-453, 2020.

	P-154. We look at the rear about the azacitidine therapy for the transplant non-adaptation high risk myelodysplastic syndrome and analyze a mark 山崎聡, 門脇賢典, 高瀬謙, 岩崎浩己 Japanese Journal of Transfusion and Cell Therapy 66(2): 453-453, 2020.

	P-155. Usefulness of low-dose methotrexate/tacrolimus in the GVHD prevention at the cord-blood transplant 飯野昌樹, 佐藤友哉, 坂本勇磨 Japanese Journal of Transfusion and Cell Therapy 66(2): 454-454, 2020.

P-156. The autoimmune acquired haemophilia A which occurred all over the course of the pulmonary lymphoproliferative disorder with autoimmune disease and the serum IgG4 high level
村上純1), 安村敏2), 梶川清芽1), 在田幸太郎1), 和田暁法1), 大槻晋也2), 富山隆介2), 中出祥代2), 佐竹伊津子2), 道野淳子2), 山本由加里2), 佐藤勉1)
Japanese Journal of Transfusion and Cell Therapy 66(2): 454-454, 2020.

P-157. An example of the B-cell acute lymphoblast-like cell line that granulocytes infusion was effective for severe invasive fungal diseases
小林宏紀1), 藤井敬子1,2), 藤原かおり3), 金光喜一郎3), 石田悠志3), 清家圭介1,4), 三道康永1,4), 池川俊太郎1,4), 松田真幸1,4), 近藤匠1,4), 木村真衣子1,4), 高木尚江4,5), 鷲尾佳奈3), 嶋田明3), 藤井伸治1,4)
Japanese Journal of Transfusion and Cell Therapy 66(2): 455-455, 2020.

	P-158. One case in acknowledgment of serious blood transfusion reaction 村井良精1), 盛合美加子1), 片山雄貴1), 北山育実1), 柳原希美1,2), 田中信悟1,2), 高橋聡1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 455-455, 2020.

	P-159. Protein collect rate of the ascitic filtration concentration re-IV infusion law in our hospital 坪倉美里1), 松下弘道1), 竹内紗耶香1), 笠根萌美1), 中林咲織1), 加瀬由貴1), 岩下奈央1), 小島稔2), 川村公彦1), 林智晶1) Japanese Journal of Transfusion and Cell Therapy 66(2): 456-456, 2020.

	P-160. Red blood cell apheresis for the hyperferremia complicated with dehydration type hereditary stomatocytosis 石田篤正1), 榧木美佳1), 中島久晴1), 高木豊雅1), 津田勝代1), 枡尾和江1), 胡内久美子1), 八木秀男2), 小倉浩美3), 青木貴子3), 菅野仁3), 中村文彦1) Japanese Journal of Transfusion and Cell Therapy 66(2): 456-456, 2020.

	P-161. One case of the acute previous marrow acute leukemia that developed iliopsoas muscle bleeding on the next day of the transfusion-associated circulatory overload 奥田慎也1), 朝倉信之介2), 竹林ちあき1) Japanese Journal of Transfusion and Cell Therapy 66(2): 457-457, 2020.

	P-162. One mother children case that showed thrombocytopenia together 因幡朱理1), 外本裕一1), 松下悠紀2), 杉浦多佳子3), 小川伸二3), 門脇賢典4), 服部幸子1), 竹山朋希1), 松下義照1), 荒川仁香1) Japanese Journal of Transfusion and Cell Therapy 66(2): 457-457, 2020.

	P-163. 1 case that developed the transfusion syndrome between mother children in the irregular antibody possession pregnant woman 大塚幸成1), 熊谷佳奈江1), 織田喜子1), 佐々木菜緒1), 渋谷賢一1), 高瀬優1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 458-458, 2020.

	P-164. About the detection situation of the maternal antibody in our hospital 山本真富果1), 遠藤啓1), 富松貴裕1), 宮崎泰彦1), 楢原久美子2), 奥廣和樹2), 高田寛之2), 大塚英一2) Japanese Journal of Transfusion and Cell Therapy 66(2): 458-458, 2020.

	P-165. Process and the current situation until operation for the obstetric critical bleeding in our hospital 松田和樹, 久保田友晶, 守屋友美, 及川美幸, 千野峰子, 木下明美, 岡田真一, 中林恭子, 岡本好雄, 槍澤大樹, 菅野仁 Japanese Journal of Transfusion and Cell Therapy 66(2): 459-459, 2020.

	P-166. Effect by the massive bleeding simulation enforcement in our hospital obstetrics 菅谷紗起, 新井裕介, 渡邉真由美, 齋藤寿美, 長谷川雄一 Japanese Journal of Transfusion and Cell Therapy 66(2): 459-459, 2020.

	P-167. Examination of extraction and the correspondence of the problem by the super urgent cesarean operation simulation analysis 西田菜穂, 坂本明日香, 中村和代, 深川良子, 野崎昭人 Japanese Journal of Transfusion and Cell Therapy 66(2): 460-460, 2020.

	P-168. Analysis of the recipient blood group antigen residual cause after the ABO second mismatch cord-blood transplant 水村真也, 吉井真司, 関紀子, 櫻井梨恵, 高橋里奈, 芳野達弘, 高橋みどり, 府川正儀, 牧野茂義 Japanese Journal of Transfusion and Cell Therapy 66(2): 460-460, 2020.

	P-169. Difference between serovar and blood-forming organ tumor in mixed field agglutination found in an ABO blood group system judgment 横濱章彦1), 西本奈津美1), 岩原かなえ1), 石川怜依奈1), 須佐梢1), 丸橋隆行1), 関上智美1), 早川輝2), 高橋遥一郎2), 佐野利恵2), 小湊慶彦2) Japanese Journal of Transfusion and Cell Therapy 66(2): 461-461, 2020.

P-170. Aichi multicenter study ... for examination - healthy subjects of the difference of the automatic analytical procedure and tube test in the antiA/B titration
杉浦縁1), 松浦秀哲1), 松野貴洋1), 荒川章子1), 白木真理1), 林由芽1), 加藤千秋2), 深見晴恵3), 石原慶子3), 丹羽玲子4), 林恵美4), 藤井紀恵5), 三浦康生1,5)
Japanese Journal of Transfusion and Cell Therapy 66(2): 461-461, 2020.

	P-171. Basic examination of ECHO Lumena 加藤千秋1), 西田謙登1), 川上萌1), 遠藤比呂子1), 渡邊友美1), 松下正2) Japanese Journal of Transfusion and Cell Therapy 66(2): 462-462, 2020.

	P-172. c.204-9T>C mutation of the interleaved array 4 associated with the A1B3 type 白石莉紗子1), 河井妙保2), 荻山佳子3), 伊藤正一3), 清水幸代4), 横家信華4), 小野寺孝行2), 山崎久義5), 渡邉聖司5), 伊佐和美1), 小笠原健一1), 内川誠2), 佐竹正博1) Japanese Journal of Transfusion and Cell Therapy 66(2): 462-462, 2020.

	P-173. One case that the attenuation of the RhD antigen was seen in 大嶋祐喜1), 海老田ゆみえ1), 坂井晴香1), 増永志穂1), 新家裕朗2), 大蔵美幸2), 森田美穂子2), 根来英樹2), 細野奈穂子2), 松田安史1,2), 浦崎芳正3), 山内高弘1,2) Japanese Journal of Transfusion and Cell Therapy 66(2): 463-463, 2020.

	P-174. 1 case thought to be neonates alloimmunity thrombocytopenia (NAIT) due to HLA antigens 松永光博1), 田中智恵美1), 島崎敦3), 牧山純也4), 跡上直2), 角至一郎3), 森内幸美4) Japanese Journal of Transfusion and Cell Therapy 66(2): 463-463, 2020.

	P-175. Comparison of the HLA antibody specificity identification reagent 澤田良子, 中村潤子, 高橋奈緒実, 川端みちる, 名倉豊, 池田敏之, 岡崎仁 Japanese Journal of Transfusion and Cell Therapy 66(2): 464-464, 2020.

	P-176. Form observation of the platelet to chill and preserve using the image analysis particle size distribution meter 福田香苗, 小池敏靖, 平山順一, 柴雅之, 宮田茂樹, 五十嵐滋, 佐竹正博 Japanese Journal of Transfusion and Cell Therapy 66(2): 464-464, 2020.

	P-177. Examination about the effect of the platelet transfusion on ITP case with the haemorrhage symptom 又野禎也1,2), 尾崎智恵1), 岩崎浩1), 水上かよ子1), 松浦絵里香2) Japanese Journal of Transfusion and Cell Therapy 66(2): 465-465, 2020.

	P-178. Examination of transportable time with RBC Conster II, a temperature stabilizer for red blood cell product transportation 中村圭太1), 曽根順子1), 大城戸秀樹1), 中島裕貴2), 大桐伸介2), 大橋晃太3), 加藤恒生1) Japanese Journal of Transfusion and Cell Therapy 66(2): 465-465, 2020.

	P-179. Effect of the blood vibration by a blood conveyance (the fourth report) drone, the vehicle conveyance by the unmanned plane drone 薬師寺史厚1,2), 薬師寺恒紀3), 武田圭史4), 村田実希郎5), 廣井直樹5), 藤田浩6) Japanese Journal of Transfusion and Cell Therapy 66(2): 466-466, 2020.

	P-180. About the transportation experiment of blood products for the transfusion by the drone 岡田英俊1), 小田原弘周1), 村上文一1), 小山龍太朗2), 庄司寛隆3), 川岡友輝4), 貞森拓磨5), 細川和浩1), 小林正夫1), 椿和央1) Japanese Journal of Transfusion and Cell Therapy 66(2): 466-466, 2020.

	P-181. What changed as a result that a blood storage place withdrew from the Amami group of islands; the second report? 園田大敬1), 清武貴子1), 中野秀人1), 原純2), 松浦甲彰3), 園田泰寿4), 大木浩5) Japanese Journal of Transfusion and Cell Therapy 66(2): 467-467, 2020.

P-182. The Amami blood rotation establishment course and problems in the settings viewpoint of the transfusion laboratory technician
清武貴子1), 園田大敬1), 中野秀人1), 大木浩1,6), 舞木弘幸2), 外室喜英2), 宮元珠華2), 原口安江2), 古城剛2), 江口夏津希2), 奥沙織3), 森千奈美4), 中島彩乃5), 藤山裕輝5), 竹原哲彦6,7), 古川良尚2,6), 田中朝志8)
Japanese Journal of Transfusion and Cell Therapy 66(2): 467-467, 2020.

	P-183. Examination of the preserved blood-style autotransfusion in the local core hospital 九里孝雄1,4), 鈴木久仁子2), 藤田沙耶花2,4), 高木悠輔2), 加藤ななみ2), 渡邊有里耶2), 高木佳耶2), 岩田智久2), 安永亨3), 川口信哉1), 新谷史明1) Japanese Journal of Transfusion and Cell Therapy 66(2): 468-468, 2020.

	P-184. The current situation of the autotransfusion in our hospital and role of the examination department transfusion examination room 彼谷裕康1), 浜田麻由子2), 村山洋子2), 徳満尚子2) Japanese Journal of Transfusion and Cell Therapy 66(2): 468-468, 2020.

	P-185. The current situation of the preserved blood-type pre-operative autologous blood donation for the artificial joint replacement in our hospital 入内島裕乃1,2), 増田志帆美3), 入内島崇紀4), 丸山茂樹1) Japanese Journal of Transfusion and Cell Therapy 66(2): 469-469, 2020.

	P-186. The current situation of the autotransfusion in the Shizuoka Prefectural children Hospital 石崎竜司1), 望月舞子4), 松島江理4), 川口晃司3), 諏訪まゆみ2), 堀越泰雄3) Japanese Journal of Transfusion and Cell Therapy 66(2): 469-469, 2020.

	P-187. The renal-transplant recipients who received preserved blood-style autotransfusion 吉田こず恵1), 佐々木奈保2), 久保光輝2), 吉田恵子3), 千田文枝3), 松橋優希3), 村上美月3), 米田真也4), 鈴木啓二朗5) Japanese Journal of Transfusion and Cell Therapy 66(2): 470-470, 2020.

	P-188. Effect by the cryopreservation of the self-fibrin paste which we manufactured by the preparation device method 芳野達弘, 高橋里奈, 関紀子, 櫻井梨恵, 水村真也, 吉井真司, 高橋みどり, 府川正儀, 牧野茂義 Japanese Journal of Transfusion and Cell Therapy 66(2): 470-470, 2020.